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Predicting Surgical Site Infection in Pediatric Patients Undergoing Spinal Deformity Surgery 
Hiroko Matsumoto 
 
The incidence of surgical site infection (SSI) in pediatric spinal deformity has been 
reported to remain high in the United States in spite of efforts made to reduce SSI.  The risk of 
SSI is associated with multiple factors. For example, the heterogeneity of patients with different 
clinical and surgical characteristics in this population imposes challenges to identify the most 
beneficial preventive strategies for individual patients. This dissertation sought to advance 
understanding of risk factors and preventive strategies for SSI in individual pediatric patients 
undergoing spinal deformity surgery.  
Although the literature reports various risk factors and preventive strategies associated 
with SSI, there are no reliable review papers using formal methodology to aggregate evidence. 
The first aim of the dissertation was to conduct a systematic review and a meta-analysis to assess 
published literature investigating associations between various risk factors and SSI in pediatric 
patients undergoing spine surgery. The systematic review and the meta-analysis were conducted 
among peer-reviewed journals published in English between January 2000 - April 2019 using the 
Preferred Reporting Items for Systematic review and Meta-Analysis (PRISMA-P). Studies 
included pediatric patients with spinal deformity undergoing surgical procedures in North 
America and were assessed for risk factors of SSI. Of 763 articles identified, thirteen met 
inclusion criteria after abstract or full manuscript review, and seven studies were rated as average 
and six as poor based on the quality checklist. The meta-analysis identified obesity/overweight, 
 
 
neuromuscular etiology, gastrostomy tube, non-ambulatory status, pelvic instrumentation, and 
high estimated blood as significant risk factors for SSI.  
 Because the published literature does not identify which individual patients are at high 
risk for SSI, the second aim of this dissertation was to create a calculator using prediction 
modeling including patient, surgical and hospital characteristics to quantify the risk of SSI in 
individual patients.  A retrospective cohort study was conducted using a database from seven 
centers that included 3,092 pediatric patients (0-21 years of age) with spinal deformity who 
underwent primary, revision, or definitive spinal fusion from 2004 to 2018. A total of 132 SSI 
(4.5%) within 90 days after surgery were identified. Candidate risk factors in this study included 
31 patient, 12 surgical and 4 hospital factors that were present or determined before the surgery 
and unlikely to be modifiable. The final prediction model achieved adequate predictive ability 
(area under the curve [AUC]: 0.76) and included 10 risk factors: overweight/obese, 
neuromuscular etiology, American Society of Anesthesiologist Physical Status Classification 
System (ASA) >1, non-ambulatory status, abnormal hemoglobin (HGB) level, high white blood 
cell (WBC) count, revision surgery, presence of pelvic instrumentation, procedure time for ≥7 
hours, and <100 spine surgical case per year per institution.  Based on these findings, a risk 
probability calculator to predict the risk of SSI in individual patients was developed. 
There are a number of preventive strategies that have been recommended in consensus-
based guidelines in the United States. The third aim of this dissertation was to investigate the 
association between preventive care measures and SSI and predict the reduction of SSI 
probability in individual patients by these preventive strategies. The database used in Aim 2 was 
also utilized to investigate the association between preventive care measures and the risk of SSI. 
Examined preventive strategies were the use of topical vancomycin, povidone-iodine irrigations, 
 
 
multilayered closure, impermeable dressing, the enrollment in Children’s Hospitals’ Solutions 
for Patient Safety (SPS) program or in the Comprehensive Unit-based Safety Program (CUSP), 
and adherence to the institutional perioperative antibiotic prophylaxis guideline. None of these 
preventive strategies were included in the risk model from Aim 2. When the CUSP/SPS 
enrollment alone was in the model, patients whose procedures were performed when sites were 
enrolled in the programs had 49.4% decrease in SSI (odds ratio [OR]:0.51, [95% CI: 0.32; 0.81], 
p=0.005) and AUC of 0.56. When CUSP/SPS enrollment was added to the risk model from Aim 
2, the model revealed that patients whose procedures were performed when sites were enrolled in 
the CUSP/SPS had an average 48.9% decrease in SSI (odds ratio: 0.51, [95% CI: 0.29; 0.82]). 
The final prediction model demonstrated adequate predictive ability (AUC: 0.77).  
This dissertation highlighted factors associated with an increased risk of SSI and 
preventive strategies related to a reduced risk of SSI in pediatric patients undergoing spinal 
deformity surgery. The results of this study will enable healthcare providers to calculate the risk 
of SSI and effects of preventive strategies in reducing the risk of SSI in individual patients. In the 
long term, the information from this study could be used to enhance personalized care in clinical 
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Chapter 1:  Introduction & Overview of the Dissertation 
 
Pediatric spinal deformity is one or a combination of scoliosis, kyphosis and lordosis, and is 
estimated to have an impact on over 1.25 million children aged 0-18 in the United States1–7. 
Scoliosis, kyphosis and lordosis are defined as a lateral curvature of the spine greater than ten 
degrees, an abnormal thoracic curvature of spine on sagittal plane and an abnormal lumbar 
curvature of spine on sagittal plane, respectively. Spinal deformity in children can be subject to 
rapid progression of the spinal curvature, pulmonary or cardiovascular compromise, and 
neurological deficits, all of which can have a profound effect on HRQoL8–10. Generally, 
operative treatment is recommended when a scoliosis becomes greater than 40-50 degrees in a 
growing child (Figure 1.1) 11–16. However, the overall risk of complications following surgical 
intervention in this population remains high, ranging from 3.9% to 40.1%17–22.  
 
 
Figure 1.1 Preoperative (left) and postoperative (right) radiographic images of spinal 
deformity 
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 Of the possible complications in pediatric scoliosis surgery, surgical site infection (SSI) 
has been reported to range from 0% to 26.3% in the United States (Figure 1.2) 17,23–39. Once it 
has occurred, SSI usually results in substantial burden to patients, families, physicians, hospitals 
and payers as its treatment involves long-term antibiotic prophylaxis, multiple surgeries for 
repeated irrigation and debridement, implant retention, removal, or revision surgery40,41. The 
subsequent consequence of these treatments is prolonged hospitalization ranging from 6 to 171 
days and immense financial cost from $16,977 to $961,72240. Because of these extensive 
burdens, considerable efforts to prevent SSI have been made. However, substantial variation still 
exists in SSI prevention practices for pediatric patients undergoing spinal deformity surgery42–44. 
 
 
Figure 1.2 Picture of surgical site infection 
 
 In order to add knowledge to the field, there are several critical questions to be answered. 
First, “What are the known risk factors related to SSI in pediatric patients undergoing current 
spinal deformity surgery?” Although there have been integrative reviews of the risk factors of 
SSI in patients undergoing spinal deformity surgery45–50, none have focused only on the pediatric 
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population and/or current surgical techniques. Existing review papers included adults45–50 and/or 
outdated surgical techniques in 1980s and 1990s45–50. Additionally, no reviews utilized a formal 
review process as described in the reporting items for systematic review and meta-analysis 
protocols (PRISMA-P). Lacking rigorous methodologies and the mix of host populations and 
surgical procedures in these review papers may have led to the difficulty in interpreting evidence 
and allowed a wide range of SSI preventive practices and incidences of SSI.  
 In Chapter 2 of this dissertation, a systematic review and meta-analysis were formally 
performed to assess quality of the literature related to risk factors for SSI in pediatric patients 
undergoing spinal deformity surgery. The Preferred Reporting Items for Systematic Reviews 
(PRISMA) 51, the Cochrane Consumers and Communication Review Group’s data extraction 
template51, and a 27-item checklist for the assessment of the methodological quality52 were 
utilized to identify and evaluate peer-reviewed journals.  Reviewed papers included only 
pediatric patients undergoing surgical procedures between January 2000 – April 2019, when the 
currently accepted surgical procedure was used. Meta-analysis was performed to calculate 
weighted risk ratios and mean differences for each risk factor to consolidate the current evidence 
in a formal manner. 
 The second important question is “Who is at high risk of SSI?” The literature reports 
various risk factors related to the patient host, surgical procedures, and hospital practices 
including antibiotic prophylaxis17,23,25,32,33,35,38,39,53–55  which are associated with SSI in pediatric 
patients undergoing spinal deformity surgery45–50. These investigations on associations between 
risk factors and SSI or between interventions and reduction of SSI, however, cannot identify 
which patients will benefit from of management of risk factors or implementation of preventive 
strategies. Prediction models used in this dissertation allowed us to assess the probability of SSI 
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in individual patients. Three predictive models for SSI have previously been published in the 
field of pediatric spine deformity, but each model had major limitations in methodology mainly 
from a lack of clinical data and limited testing with few institutions32,33,56. For example, the 
National Surgical Quality Improvement Program (NSQIP) pediatric surgical risk calculator used 
Current Procedural Terminology (CPT) codes which was formed to maximize the reimbursement 
from payers56. A second model used administrative data and billing codes33, which are known to 
have poor correlation with medical records57,58. These two models used databases created to 
serve for financing aspects and do not necessary include information that is granular enough for 
clinical research. The third model only included one surgical procedure from a single hospital32. 
Therefore, a predictive model, which includes clinical information and is specific to pediatric 
patients undergoing various spinal deformity surgeries is lacking in the field.  
 To this end, in Chapter 3 of this dissertation, a study was conducted to create and validate 
a risk probability calculator to assess the probability of SSI within 90 days after spinal deformity 
surgery in individual patients aged 0-21 years.  Risk factors included 31 patient, 12 surgical, and 
4 hospital risk factors present or planned preoperatively and unlikely be modifiable. Therefore, 
the risk calculator can be used in the clinical setting when patients are scheduled for surgery for 
their spinal deformity. In order to identify risk factors and determine a model with the best 
possible discrimination and calibration abilities, prediction modeling and five-fold cross 
validations were utilized. As a result, a risk prediction algorithm and a mobile device application 
were developed from the model to calculate the individual probability of SSI and to be utilized in 
the real-world clinical setting.  
 The third key question is “How can the risk of SSI be reduced in individual patients?” 
For example, one may ask whether hospital enrollment in a quality program requiring intensive 
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commitments and resources have an effect on reducing the risk of SSI in a particular patient. 
There are considerable variations in prevention practices 42–44,59 possibly due to inconsistent 
findings in the literature17,23,25,32,33,35,38,39,53–55. These inconsistencies may imply that the 
magnitude of associations between preventive strategies and the risk of SSI differ according to 
different host population with heterogeneous preoperative characteristics and various surgical 
procedures. Current literature investigating associations between preventive strategies and the 
risk of SSI, however, reports associations at the population level but not at the level of the 
individual patient.  
 In Chapter 4 of this dissertation, prediction modeling was utilized to investigate the 
association between preventive care measures and the risk of SSI and predict the reduction of 
SSI probability in individual patients related to these measures. Preventive care factors examined 
are commonly used SSI preventive strategies in the United States: the use of topical vancomycin 
in the operative site and/or bone graft, povidone-iodine irrigations, multilayered closure, 
impermeable dressings, the enrollment in Children’s Hospitals’ Solutions for Patient Safety 
(SPS) program or in the Comprehensive Unit-based Safety Program (CUSP), and adherence to 
antibiotic prophylaxis.  The odds ratios comparing SSI in patients who received or did not 
receive these preventive care factors were calculated and five-fold cross validations were utilized 
to examine predictive abilities models. A risk prediction algorithm and a mobile device 
application were developed from the final model to express the reduction of SSI risk in 
individual patients from the risk probability yielded in Chapter 3.   
 The major goal of this dissertation was to create a risk probability calculator by 
prediction modeling to assess the probability of SSI in individual pediatric patients when they are 
scheduled to have spine surgery and develop a prediction model to identify effective preventive 
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care to reduce the probability of SSI in these individual patients (Figure 1.3).  Development of 
prediction models and investigation on causal inference are different in principle and model 
selection (Figure 1.4). The central principle of causal inference is that inferences are made about 
a population from an extracted sample. On the other hand, the central principle of prediction is 
that sample data from a population with two different outcomes we would like to predict 
(developing or not developing SSI) are used to build a prediction function based on some 
properties. When a new sample of patients is obtained, the prediction function assigns each 
patient to developing or not developing SSI based on those properties. In model selection, causal 
inference modeling is performed by accounting for confounders and effect modifiers to infer 
causation from associations that can be observed. On the other hand, prediction modeling selects 
factors to maximize the prediction of the outcome. It is important to note, however, that causal 
inference and prediction are related. Strong causal factors identified in an investigation of causal 
inference likely drive prediction models as well.   
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Figure 1.3 A SSI Risk Probability Calculator and Potential Effect of Preventive Care 
Factors 
 
Figure 1.4 Differences in Principles between Development of Prediction Models and 
Investigation on Causal Inference 
  8 
 Empirical evidence from this dissertation will help advance understanding of risk factors 
for SSI and may in the long term be used to implement preventive strategies to reduce the risk of 
SSI in pediatric patients undergoing spinal surgery. The risk probability calculator yields a single 
value from various combinations of number of risk factors allowing us to consider which 
surgical risk factors come to play under what hospital circumstance and to whom. The etiology 
of the spinal deformity, for example, is not modifiable; however, by applying certain preventive 
care measures and appropriately allocating efforts and resources in individual patients, it could 
reduce the risk of SSI. Reduction of SSI reduces a substantial burden from some patients, 
families, physicians, hospitals and payers by avoiding long-term antibiotic prophylaxis, multiple 
surgeries prolonged hospitalization and immense financial cost. Prevention of SSI can also 
prevent deterioration of health-related quality of life of patients and families as well as morbidity 
and mortality.  
 The proposed work is also important at other levels.  First, a risk probability calculator 
could facilitate informed counseling and shared decision-making with patients and families when 
surgery is being planned. Shared decision-making has been promoted in academia60 and 
government (Washington State Legislature. RCW 7.70.060) as an alternative to the traditional 
informed consent process notifying patients and their families of treatment plans determined by 
healthcare providers. In this process, high quality evidence must be disseminated and used to 
support the shared decision-making. However, a large collection of literature with various host 
populations and SSI definitions may impose a challenge in interpreting evidence relevant to 
individual patients and their families especially when multiple risk factors need to be considered. 
The meta-analysis of risk factors and a single tangible score of risk probability produced in this 
dissertation could be useful in discussions with patients and their families. Second, a risk 
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probability scoring could be used as a tool for risk adjustment. The Centers for Medicare & 
Medicaid Services (CMS) use incidence of readmission as a publicly reported quality metric and 
plan to decrease reimbursement to hospitals with high incidence of readmission61. However, if 
reimbursements are based on the incidence of readmission alone and are not adjusted properly 
for patient-specific risk, there is reduced incentive for a hospital to provide services to high-risk 
patients. SSI is one of the most common causes for hospital readmission28,62,63 and risk 
prediction models for SSI can be a useful risk adjustment tool to calculate incidence of 
readmission with standardized risk. This risk-standardized readmission then can be used for 
hospital comparison, public reporting, and reimbursement determinations.   
 In summary, studies were conducted in this dissertation with the following specific aims. 
Aim 1. To conduct a systematic review and a meta-analysis to assess published literature 
investigating associations between various risk factors and SSI in pediatric patients undergoing 
spine surgery (Chapter 2). To create a risk probability score using prediction modeling 
including patient, surgical and hospital characteristics to quantify the risk of SSI in individual 
patients (Chapter 3). To investigate the association preventive care measures and SSI, and 
predict the reduction of SSI probability in individual patients by these preventive care (Chapter 
4). Studies to meet these aims will have a broad impact on the field by providing information in 
clinical practice to enhance personalized care and tailor care practice to improve outcomes of 
surgery in each patient.  
 
 
  10 
Chapter 2: Risk Factors Associated with Surgical Site Infection 
in Pediatric Patients Undergoing Spinal Deformity Surgery: A 




Considerable variation exists in surgical site infection (SSI) prevention practices for pediatric 
patients undergoing spinal deformity surgery, but the incidence of SSI has been reported to 
remain high in United States. The literature reports various risk factors associated with SSI but 
findings are inconsistent. The purpose of this systematic review and meta-analysis was to assess 
published literature investigating associations between various risk factors and SSI in pediatric 
patients undergoing spine surgery.  
 
Methods 
The systematic review and the meta-analysis were conducted using PRISMA-P guidelines 
among peer-reviewed journals. Inclusion criteria were studies published in English between 
January 2000 – April 2019 with abstract and full manuscripts including pediatric patients aged 0-
21 years with spinal deformity undergoing surgical procedures performed 2000 on (not before) 
in North America. Studies also needed to investigate SSI as the primary outcome and its risk 
factors to be included in this study. Quality of individual studies was assessed, and weighted risk 
ratios and mean differences were calculated for each risk factor.  
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Results 
A total of 763 potential articles were identified and 750 articles were excluded due to not 
meeting inclusion criteria such as including surgical procedures performed before 2000, 
including patients >21 and not investigating risk factors for SSI. Of thirteen articles meeting 
inclusion criteria, seven studies were rated as average and six as poor quality based on the 
checklist. The meta-analysis demonstrated the following increased risks of SSI: 2.53 (95% CI, 
1.26 to 5.10) for obese/overweight (BMI ≥25 or ≥85 percentile) patients compared to patients 
with healthy weight (BMI > 18.5 and <25 or >5 percentile and <85 percentile), 2.84 (95% CI, 
1.67 to 4.81)) for patients with neuromuscular etiology compared to non-neuromuscular etiology, 
1.69 (95% CI, 1.41 to 2.02), for patients with a G-tube compared to those without, 3.45 (95% CI, 
2.08 to 5.72) for non-ambulatory patients compared to ambulators, 3.39 (95% CI, 2.38 to 4.83 ) 
for patients with pelvic instrumentation compared to those without. Patients who developed SSI 




Despite the limited quality of studies and wide variety of populations and outcome definitions, 
evidence suggests that obesity/overweight, neuromuscular etiology, use of G-tube, non-
ambulatory status, instrumentation to pelvis and higher EBL are risk factors for SSI. There was a 
gap in evidence that underweight, CP, higher ASA score, prior spine surgery, any surgical type 
or longer duration of surgery was associated with increased risk of SSI. The use of a common 
SSI definition and adequate confounder control are warranted for future studies.  
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2.2. Introduction 
Surgical site infection (SSI) after surgery for spinal deformity in pediatrics has been reported to 
range from 0% to 26.3% in the United States17,23–39 and may result in substantial burden to 
patients, families, physicians, hospitals and payers. Treatment of SSI entails long-term antibiotic 
prophylaxis, multiple surgeries for repeated irrigation and debridement, implant retention, 
removal, or revision surgery40,41. The treatments for SSI subsequently result in prolonged 
hospitalization and immense financial cost. Hedequis et al. reported that the additional hospital 
days related to the SSI range from 6 to 171 days, and related hospital charges from $16,977 to 
$961,72240. Because of this extensive burden, interventions focusing on preventing SSI have 
been of interest.  
 Despite ongoing efforts, considerable variation and uncertainty still exist in infection 
prevention practices by health care providers42–44,59. Reviews of literature have documented 
multiple risk factors, including patient, surgical, hospital and antibiotic prophylaxis-related 
factors, to be associated with SSI in pediatric patients undergoing spinal deformity surgery45–50. 
However, there are inconsistencies in findings, possibly due to factors such as differences in host 
populations, therapeutic practices across sites, documentation, or definitional variations. 
Difficulty in interpreting and evaluating these results could have led to the existing uncertainty in 
clinical practice. This systematic review evaluated the literature assessing associations between 
various risk factors and SSI using formal review techniques.  
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2.3. Materials and Methods 
This study utilized the Preferred Reporting Items for Systematic review and Meta-Analysis 
(PRISMA-P)64. 
 
Information Sources and Eligibility Criteria 
The systematic review was conducted by searching PubMed and Ovid MEDLINE for existing 
peer-reviewed studies in English published from January 2000 through April 2019 with abstracts 
and full texts. The year 2000 was chosen based on the wide utilization of segmental spinal 
instrumentation with pedicle screws for pediatric spinal deformities since that time. Studies 
including patients aged 0-21 years with spinal deformity were eligible for the review. Surgical 
procedures included were limited to those performed in North America as perioperative care and 
environmental factors including physical, regulatory and technological environment may have 
differed significantly in other countries. Any study that investigated SSI as the primary outcome 
and its risk factors was included, regardless of how SSI was defined.  
 
Search and Study Selection 
The search terms with a combination of Medical Subject Headings (MeSH) terms or/and text 
words described in Table 2.1 were used. Three pediatric spine surgeons from the Department of 
Orthopaedic Surgery at Columbia University Irving Medical Center were consulted to identify 
relevant and inclusive search terms related to the pediatric population, diagnosis and surgical 
procedure. Search terms for SSI were discussed with an infectious disease specialist from the 
Department of Pediatrics. To refine search terms and ensure that a comprehensive search strategy 
was used, a medical librarian in the Department of Orthopaedic Surgery was consulted. A 
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complete list of search terms is documented in Table 2.1.  All identified articles were stored in 
Mendeley (https://www.mendeley.com), a program managing references and generating 
bibliographies, and duplicates were removed. Initial manual screening and determining eligibility 
by title and abstract were performed independently in an unblinded standardized manner by two 
reviewers. The full text of manuscripts deemed relevant after initial screening were then 
reviewed by the same two reviewers to determine if each article met the inclusion criteria; 
disagreements between the two reviewers were resolved by consensus. The Preferred Reporting 
Items for Systematic Reviews (PRISMA) flow diagram was used to summarize study selection 
processes51.  
  15 
Table 2.1 Description of Literature Search Terms 
Categories  Terms 
Population (age <21) pediatric, child*, adolescent*, youth*, young adult*, infant*, 
baby, babies, toddler* 
Diagnosis spinal deformit*, spinal curvature*, spine curvature, scoliosis, 
kyphosis or lordosis 
Surgical Procedure surgery, surgeries, surgical procedure*, instrumentation*, 
fusion*, spinal fusion*, spinal arthrodesis, osteotom*, vertebra 
column resection, ponte, decompress* 
Outcome (SSI) wound infection*, surgical site infection*, postoperative 
infection*, post-operative infection*, post operative infection*, 
gram-negative infection*, gram-positive infection* 
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Data Collection and Data Items 
A data extraction sheet was developed based on the Cochrane Consumers and Communication 
Review Group’s data extraction template51. The first reviewer extracted the data from included 
studies and the second reviewer checked a 10% random sample of the extracted data. Any 
disagreement was resolved by discussion between the two reviewers. The following information 
was extracted from the final articles: authors, year of publication, study design, country in which 
the study was conducted, inclusion and exclusion criteria of study participants, sample size, 
analytic approach, types of risk factors including patient, surgical, hospital and antibiotic 
prophylaxis factors, definitions of SSI, and findings related to risk of SSI.  
 
Assessment of Bias and Statistical Analysis  
Quality of individual studies was assessed independently by the two reviewers using a 27-item 
checklist for the assessment of the methodological quality52. The checklist assessed four study 
characteristics: reporting, external validity, internal validity (bias and confounding) and power 
and a total quality rating was assigned (Appendix 2.1). The level of evidence described in the 
Journal of Bone & Joint Surgery (JBJS)65 was also examined. When an exposure was 
investigated by more than one study and raw data was available, meta-analysis was performed. 
For dichotomous exposures, risk ratios (RR), 95% confidence intervals (CI) and for continuous 
exposures, mean difference and their standard deviations (SD) were calculated using random 
effect model66. Random effect model over fixed effect model was utilized since a degree of 
variability was expected67,68. The magnitude of the between-studies variability (heterogeneity) 
was calculated using tests of heterogeneity and I2 statistic69.  
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2.4. Results 
Study Selection 
A total of 763 potential articles were identified by using the literature search terms (Figure 2.1). 
By screening titles and abstracts, 727 articles were excluded after applying the inclusion criteria. 
Majority of articles were excluded for not meeting the following criteria: SSI as not a primary 
outcome (86.2%); not investigating risk factors (85.7%); surgery performed outside North 
America (55.7%); adult patients included (37.9%); surgery performed before 2000 (32.8%). 
Thirty-six manuscripts underwent full text review and 23 of 36 were excluded for the following 
reasons: (1) included surgical procedures done before 2000 (n=10), (2) included patients older 
than 21 years of age (n=7), (3) no risk factors investigated for SSI (n=6). The evaluation of 
manuscript quality was conducted on thirteen papers.  
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Figure 2.1: Flow Diagram of Article Selection 
 
  
Manuscripts identified through 
Pubmed (N = 359) 
Manuscripts identified through 
OVID/Medline (N = 691) 
Manuscripts after duplicates 
removed (N = 763) 
Manuscripts excluded for 
not meeting inclusion 
criteria by abstract review 
(N = 727) 
Full-text articles assessed for 
eligibility (N = 36) 
Manuscripts excluded for 
not meeting inclusion 
criteria by full-text article 
review (N = 23) 
Studies included in assessment 
of bias and method of analysis 
 (N =13) 
• Procedure before 2000 
included  (N=10) 
• Patient ages included 
>21 (N=7) 
• Not risk factor 
investigated for SSI 
(N=6) 
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Characteristics of Included Studies 
Evaluated papers included twelve studies conducted in the United Stated and one in Canada 
(Table 2.2) 23,24,32–35,70–76. There were nine retrospective cohort studies23,33–35,71,72,74–76 and two 
case-control studies32,73. Two studies used a mixed method of cohort and case-control design24,70. 
Ten studies were single-center studies32,34,35,70–76 and three recruited patients from multiple 
hospitals23,24,33. The thirteen included studies varied in their choice of study populations such as 
age, etiology, location of spinal curvature and presence of sagittal plane deformities and surgical 
procedures such as approaches and surgical procedures. Two studies included <100 patients32,73, 
nine studies had 100-500 patients24,34,35,70–72,74–76, one had 500-1,000 patients23 and one had more 
than 1,000 patients33. There were seven Prognostic Level II studies and six Therapeutic Level III 
studies.  
 The definition of SSI also differed among studies. Seven studies defined SSI using the 
Centers for Disease Control and Prevention’s National Healthcare Safety Network (CDC/NHSN) 
criteria23,32,34,70–72,75. Among these seven studies, four used CDC criteria defining deep incisional 
or organ/space SSI as SSI occurring with 90 days after surgery34,70–72; Mackenzie et al. and Croft 
et al. used the previous definition which considered these SSI as occurring within 1 year23,3223. 
One study did not provide details or a reference on which CDC criteria they used75. Five studies 
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Table 2.2 Summary of main characteristics of manuscripts included in the systematic review  
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Seven studies were rated as average quality23,32,34,71,72,74,75 and six were determined to be poor 
quality 24,33,35,70,73,76 based on the quality checklist (Appendix 2.1). None of the studies reported 
characteristics of patients who were lost to follow-up nor took them into account. Adequate 
adjustment for confounding in the analyses was only performed in the Görges et al study74 and 
partially done in the Haller et al, Imahiyerobo et al, and Glotzbecker et al. studies71,72,75.  
 
Risk Factors and Preventive Interventions for SSI 
Six studies predetermined the exposure of interest included in their sample 35,71,72,74–76 while 
seven studies examined more than a dozen variables including patient, clinical, surgical, and care 
factors23,24,32–34,70,73. The a priori exposures that the six studies examined were preoperative 
warming74, gentamicin-impregnated allograft bone35, intra-wound vancomycin powder75, body 
mass index (BMI)76, plastic multilayered closure (PMC)71 and implementation of clinical 
pathway protocol72. Görges et al. reported that there were no associations between preoperative 
warming and SSI with adequate adjustment74. Imahiyerobo et al. reported that utilization of PMC 
were associated with decreased risk of SSI71. Glotzbecker paper reporting no association 
between the implementation of the pathway protocol and overall SSI but there were significant 
decreased in deep SSI from before to after the implementation. Borkhuu et al and Haller et al. 
reported that gentamicin-impregnated allograft bone and intrawound vancomycin power are 




Body Mass Index 
Body mass index was investigated in four studies: obese/overweight versus healthy weight (BMI 
> 18.5 and <25 or >5 percentile and <85 percentile) in four studies32,34,73,76 and underweight 
versus healthy weight in two studies34,73. Patients with obesity or overweight had increased risk 
of SSI compared to those with healthy weight (RR, 2.53 [95% CI, 1.26 to 5.10]; p=0.009) 
(Figure 2.2). The test of heterogeneity (p=0.155) and I2 (42.7%) indicated that there was 
moderate heterogeneity among studies. There was no evidence to demonstrate that the 
underweight group had an increased risk of SSI compared to the healthy weight group (RR, 1.85 
[95% CI, 0.83 to 4.12]; p=0.131) (Figure 2.3). The test of heterogeneity (p=0.403) and I2 (0%) 












Figure 2.3: Risk of SSI in underweight group compared to healthy weight group
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Neuromuscular Etiology 
Six studies investigated neuromuscular etiology23,24,32,34,71,73. There was an increased risk of SSI 
in patients with neuromuscular etiology compared to those without neuromuscular etiology (RR, 
2.84 [95% CI, 1.67 to 4.81]; p<0.001) (Figure 2.4). However, a heterogeneity test (p=0.038) and 
I2 (57.5%) demonstrated moderate to substantial heterogeneity among studies. Cerebral palsy 
(CP) was investigated separately in two studies32,33 but found no evidence of an increased risk of 
SSI in CP group compared to non-CP group (RR, 1.37 [95% CI, 0.68 to 2.73]; p=0.378) (Figure 
2.5). The heterogeneity test (p=0.038) and I2 (76.7%) also demonstrated that there was 











Figure 2.5: Risk of SSI in cerebral palsy (CP) group compared to non-CP group
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American Society of Anesthesiologists Score 
American Society of Anesthesiologists (ASA) score was investigated in two studies24,32.    
There was no evidence of increased risk of SSI in patients with ASA score ≥ 3	compared to 
patients with ASA score <3 (RR, 2.20 [95% CI, 0.53 to 9.10]; p=0.277) (Figure 2.6). 
Additionally, the test of heterogeneity (p=0.0003) and I2 (88.3%) demonstrated that there was 






Figure 2.6: Risk of SSI in American Society of Anesthesiologists 
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Gastrostomy Tube 
Two studies examined the presence of a gastrostomy tube (G-tube)32,33. There was an increased 
risk of SSI in patients with a G-tube compared to patients without a G-tube (RR, 1.69 [95% CI, 
1.41 to 2.02]; p<0.001) (Figure 2.7). The heterogeneity test (p=0.494) and I2 (0%) demonstrated 





Figure 2.7 Risk of SSI in gastrostomy tube (G-tube) group compared to non-G-tube group 
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Non-Ambulatory Status 
Non-ambulatory status was investigated by two studies32,73. There was an increased risk of SSI in 
non-ambulators compared to ambulators (RR, 3.45 [95% CI, 2.08 to 5.72]; p=0.005) (Figure 







Figure 2.8 Risk of SSI in Non-ambulator group compared to ambulator group 
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Prior Spine Surgery 
Two studies investigated prior spine surgery32,34. The meta-analysis of two studies found no 
evidence of increased risk of SSI in patients who had prior spine surgery compared to those who 
did not (RR, 0.92 [95% CI, 0.29 to 2.97]; p=0.891) (Figure 2.9). The heterogeneity test 






Figure 2.9 Risk of SSI in patients with prior spine surgery compared to patients without prior surgery 
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Procedure Type 
Three studies investigated procedure types23,24,34. The meta-analysis of two studies found no 
evidence of increased risk of SSI in arthrodesis procedures compared to growing construct 
procedures (RR, 0.99 [95% CI, 0.66 to 1.47]; p=0.957) (Figure 2.10)23,34. The test of 
heterogeneity (p=0.566) and I2 (0%) showed low heterogeneity between two studies. Among 
arthrodesis procedures, the same two studies showed that there was no evidence of increased risk 
of SSI in revision/converted procedures compared to primary procedures (RR, 1.20 [95% CI, 
0.62 to 2.31]; p=0.595) (Figure 2.11). The heterogeneity test (p=0.759) and I2 (0%) showed low 
heterogeneity between the two studies. Among growing construct procedures, the meta-analysis 
of three studies showed that there was also no evidence of increased risk of SSI in 
revision/converted procedures compared to insertion procedures (RR, 0.72 [95% CI, 0.33 to 
1.56]; p=0.404). (Figure 2.12) 23,24,34. The test of heterogeneity (p=0.220) and I2 (33.9%) showed 


















Figure 2.12 Risk of SSI in patients undergone growing construct insertion compared to patients undergone growing construct 
exchange/revision/removal 
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Instrumentation to Pelvis 
Two studies examined instrumentation to pelvis23,32. There was increased risk of SSI in patients 
with pelvis instrumentation compared to those without (RR, 3.39 [95% CI, 2.38 to 4.83]; 






Figure 2.13 Risk of SSI in pelvic instrumentation group compared to non-pelvic instrumentation group 
 50 
Surgical Time 
Surgical time was investigated by three studies32,34,73. The meta-analysis was performed only on 
two studies32,73 since one of them lacked information on standard deviation34. The meta-analysis 
found no evidence of an association between surgical time and SSI (Mean Difference, 51.15 
[95% CI, -36.97 to 139.27]; p=0.255) (Figure 2.14). The heterogeneity test (p=0.037) and I2 












Estimated Blood Loss 
Two studies investigated estimated blood loss (EBL)32,73 and found an association between EBL 
and SSI (Mean Difference, 158.38 [95% CI, 46.78 to 269.97];p=0.005) (Figure 2.15).Patients 
who develop SSI had 158.38 ml more EBL compere to those who did not. The heterogeneity test 








Figure 2.15 An association between estimated blood loss and SS
  54 
2.5. Discussion 
There have been previous literature reviews of risk factors of SSI in pediatric patients 
undergoing spinal deformity surgery45–50, but none focused only on the pediatric population 
and/or current surgical techniques. Previous review papers included adults45–50 and/or surgical 
techniques from the 1980s and 1990s which are now outdated45–50. Among 763 papers originally 
identified, many included adults and outdated surgical techniques. There are differences between 
pediatric and adult populations in various physical and medical features related to age including 
microbiome77,78, which protects against pathogens and educates the immune system.  Incidences 
of SSI79–81 are reported to be higher in pediatric population (0-21 years of age) and it was 
important in this study to focus specifically on pediatric patients. Additionally, this review 
included papers published only after a substantial technique change in the history for spinal 
surgery: the widespread utilization of pedicle screws connecting them with rods (i.e., spinal 
instrumentation) 82–84. In this review paper, thirteen published studies were identified that met the 
inclusion criteria.  
 To our knowledge, this is the first meta-analysis to assess factors associated with 
increased risk of SSI in pediatric patients undergoing spinal surgery. This meta-analysis 
demonstrated that obese/overweight, neuromuscular etiology, the use of G-tubes, non-
ambulatory status, instrumentation to pelvis and higher EBL were associated with increased risk 
of SSI in children. The heterogeneity was low among studies investigating the use of G-tubes, 
non-ambulatory status, instrumentation to pelvis, and EBL, however it was moderate to 
substantial among studies investigating obese/overweight or neuromuscular etiology. It is 
difficult to tease apart the main driver of heterogeneity since there were multiple differences 
between studies. Studies varied in ages of included patients, etiology of spinal deformities, year 
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published, as well as type of surgical procedure and definition of SSI.  Utilizing different 
definitions of SSI is especially problematic since various timings of SSI occurrence can be 
affected by different causal mechanisms. Some studies examined only acute SSI, and some 
included both acute and delayed SSI. Future studies should use a consistent SSI definition such 
as the CDC criteria for ease of interpretation and to enhance the strength of the evidence. There 
was no evidence that underweight as opposed to healthy or overweight/obese, CP, higher ASA 
score, prior spine surgery, any surgical type or longer duration of surgery was associated with 
increased risk of SSI. The lack of evidence may be due to the small sample size of included 
studies; therefore, more studies are needed to explore the effect of these factors on SSI.  
 The quality of each study reviewed in this paper limited our ability to determine risk 
factors and effective interventions for SSI. There were several methodological issues presented 
in these studies. First, all 13 studies were either retrospective cohort studies (9)23,33–35,71,72,74–76, 
case-control studies (2)32,73 or a mixed method of cohort and case-control design(2)24,70possibly 
due to the relatively low incidence of SSI in pediatric scoliosis. Both retrospective cohort and 
case-control study designs were limited by in a lack of data on relevant potential confounders in 
patient medical records or existing registries. Most of the studies did not adequately make 
adjustments for confounders23,24,32–35,70–73,75,76. Additionally, case-control design in two studies 
may have introduced selection bias. For example, one of the study used two controls without SSI 
matched to each SSI case who underwent surgery immediately before and after the case32. It was 
possible that the control who underwent surgery immediately after the SSI case may have been 
healthier patients (i.e. by postponing/canceling surgery for patients who failed from preoperative 
optimization) or treated with extra caution perioperatively from the care team. Second, studies 
included heterogeneous groups. For example the sample sizes varied across studies from fewer 
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than 100 to >1000 patients, and in some studies, multiple variables were examined and the main 
variable of interest for hypothesis testing was generated after the data analysis which made 
adequate confounding control to be difficult23,24,32–34,70,73. Third, while most studies reported use 
of statistical tests to examine confounder-exposure or confounder-outcome associations to 
evaluate whether confounding could occur, the magnitude of associations should have been 
considered by comparing effect measures with and without the potential confounders85. Fourth, 
none of the studies investigated the combination of potential risk factors. Factors that were not 
individually found to be risk factors could lead to SSI when combined with other factors.  Lastly, 
none of the studies reported characteristics of patients who were lost to follow-up nor took them 
into account.  Because of limitations in the studies published, the meta-analysis is based on fewer 
studies than would be desirable.  Nevertheless, aggregated information will either strengthen or 
question original studies and could still be of value to practicing orthopaedic surgeons.   
 This systematic review has several limitations. First, the review applied narrow inclusion 
criteria in terms of countries and years in which surgical procedures were performed and age of 
patients. Nonetheless, studies meeting our inclusion criteria had heterogeneous study populations 
and outcome definitions. Second, due to a wide variation of terminology, some papers may have 
been missed in the literature search. Third, papers written in languages other than English or 
unavailable through electronic library services were not included. Forth, conference abstracts or 
dissertations were not included in this review, therefore there is a chance that this review may 
reflect publication bias. Lastly, meta-analysis for each factor included only two to six 
observational studies which calls for more studies in this area.  
 Despite these limitations, this review paper is the first, to our knowledge, to utilize a 
formal and rigorous review process for systematic review and meta-analysis protocols called 
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PRISMA-P and include only pediatric patients undergoing spinal surgery with current 
techniques.  Additionally, while the JBJS levels of evidence provided a rough guide of study 
quality65 the total quality rating utilized in this study described in-depth assessments of quality of 
each study. Despite the limited quality of studies and wide variety of populations and outcome 
definitions, evidence suggests that closer attention should be paid to patients with 
obesity/overweight, neuromuscular etiology, G-tubes, non-ambulatory status, pelvic 
instrumentation and high EBL. The use of a common SSI definition and strong methodology are 
warranted for future studies. 
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Chapter 3: A Risk Probability Calculator Predicting Surgical 




 Tremendous efforts have been made to prevent surgical site infection (SSI); however, 
there is still a high incidence of SSI as up to 26.3% in patients undergoing pediatric spinal 
deformity surgery. Current literature reports various risk factors but strategies to quantify the risk 
of SSI in an individual patient have not been published. The aim of this paper is to develop and 
validate a risk probability calculator, which includes patient, surgical, and hospital risk factors 
determined or planned preoperatively and unlikely be modified to predict SSI within 90 days 
after surgery.   
 
Methods 
 Data from pediatric patients (0-21 years of age) with spinal deformity who underwent 
primary, revision, or final spinal fusion in seven institutions from 2004 to 2018 were included in 
this study. Candidate predictor variables were risk factors known preoperatively and not 
modifiable in many cases including 31 patient characteristics, 12 surgical factors and 4 hospital 
factors. The Centers for Disease Control and Prevention (CDC) definitions of SSI were used. 
Prediction modeling and five-fold cross validations were used to identify factors and determine a 
model with adequate discrimination and calibration abilities. A risk prediction algorithm and a 
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mobile device application (app) were developed from the model to calculate the individual 
probability of SSI.  
 
Results 
 3,092 spinal deformity surgical procedures and 132 SSI (4.5%) were included in this 
study. The final model achieved adequate predictive ability (area under the curve [AUC]: 0.76) 
including 10 factors: overweight/obese, neuromuscular etiology, American Society of 
Anesthesiologist Physical Status Classification System (ASA) >1, non-ambulatory status, , 
abnormal hemoglobin (HGB) level, high white blood cell (WBC) count, revision surgery, 
presence of pelvic instrumentation, procedure time for ≥7 hours, and <100 spine surgical case 
per year per institution.  
 
Conclusions 
 A risk probability calculator encompassing patient, surgical and hospital factors 
developed in this study adequately predicts the probability of 90-day SSI in pediatric patients 
undergoing spinal deformity surgery. This can be used to enhance patient education and shared 
decision making, to identify high-risk patients and to optimize care for individual patients. 
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3.2. Introduction 
Surgical site infection (SSI) following pediatric spinal surgery results in substantial 
burden to patients, families, physicians, hospitals and payers40,41. Treatment of SSI 
potentially entails readmission to hospital, long-term antibiotic treatment and multiple 
surgeries for repeated irrigation and debridement, implant retention, removal, or revision 
followed by prolonged hospitalization and an immense financial cost40,41. In response to 
the increased attention on SSI, several prevention guidelines prevention have been 
created and updated by the Centers for Disease Control and Prevention (CDC)86,87 as well 
as by other agencies88–90. Despite ongoing efforts, however, considerable variation still 
exists in SSI prevention practices42–44 and in incidence of SSI. The risk of SSI following 
spinal deformity surgery since 2000 has been reported to range from 0% to 26.3% in the 
pediatric population in the United States17,23–39.  
Current literature reports various risk factors for SSI in pediatric patients undergoing 
spinal deformity surgery23,24,32–34,70,73,76, however, such research does not quantify the risk of SSI 
in an individual patient. A risk probability calculator using prediction modeling could help to 
quantify a probability of SSI in individual patients and identify patients at high risk. Instead of 
making inferences from observed associations about population from which a study sample is 
drawn, prediction modeling makes it possible to allocate the SSI risk status in individual patients 
by creating a model function which maximizes sensitivity and specificity based on existing 
characteristics. Prior efforts in risk prediction have typically used administrative datasets with 
limited clinical information such as preoperative laboratory data (e.g. HGB), small sample sizes, 
or have lacked adequate statistical analyses such as calibration and discrimination as well as 
using appropriate variable selection method32,33,56,91. Recent emphasis on precision medicine—
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taking individual variability into consideration to select prevention and treatment options for 
specific conditions92—requires improved accuracy of predictive tools. We hypothesized that a 
risk probability calculator derived from large dataset with detailed clinical information would 
achieve adequate discrimination and calibration abilities to predict the probability of SSI within 
90 days after spinal surgery.  The purpose of this study was to create and validate a risk 
probability calculator to assess the probability of SSI in individual pediatric patients using 
prediction model, which included patient, surgical, and hospital risk factors determined or 
planned preoperatively and unlikely be modified.  
 
3.3. Materials and Methods 
The institutional review board (IRB) of each facility approved the study protocol to 
examine charts and radiographic images needed to collect data for this multi-center 
retrospective cohort study. These institutions were six academic medical centers and one 
non-academic tertiary hospital located in Northeast and West regions. Study participants 
were pediatric patients (0-21 years of age) who underwent primary, revision, or final 
spinal fusion at each site from 2004 to 2018 for their spinal deformity and received 
standard perioperative care (preoperative evaluations, hospital admission and 
postoperative visits). Number of procedures performed at each site varied greatly ranging 
from 8 to 1,490 (mean=515).  
Patient charts were reviewed by trained research personnel at each site and the status of 
SSI and preoperative known factors were entered into databases. Because some patients had 
more than one surgical procedure and the invasiveness of these procedures varied, the unit of 
data collection and analyses was procedure- rather than patient-based. De-identified data were 
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reviewed and verified by the primary author and discrepancies or ambiguities were returned to 
each institution for audit. Candidate predictor variables included preoperative and intraoperative 
risk factors not usually modifiable including patient characteristics, surgical factors and hospital 
factors (Appendix 2. 1). Patient characteristics included age, gender, height, weight, body mass 
index (BMI), etiology, magnitudes of coronal and sagittal curves, American Society 
of Anesthesiologists’ (ASA) classification of physical status, comorbidities (pulmonary, cardiac, 
behavioral, endocrine, gastrointestinal(GI), immunology, nutritional, musculoskeletal (MSK), 
neurologic), gastrostomy tube (G-tube), ventriculoperitoneal shunt (VP shunt), neuro axis, non-
ambulatory status, diaper dependence, hemoglobin (HGB) level, hematocrit (HCT) level, white 
blood cell (WBC) count, hospitalization within 2 years prior to spine surgery, prior SSI, prior 
spine surgery, prior spine SSI, and use of preoperative Halo traction. Surgical factors were type 
of surgery (primary instrumentation, definitive fusion, revision or stapling), surgical approach, 
pelvic instrumentation, number of instrumented levels, type of instrumentation (screw only or 
screw and hook), use of transfusion, use of cell saver, osteotomy, 3-column pedicle subtraction 
osteotomy (PSO)/vertebral column resection (VCR), procedure time, use of stapling as skin 
closure, and use of intraoperative skeletal traction. Hospital characteristics included geographic 
region, area (urban or rural), academic, and institutional volume of pediatric spine surgical cases.  
For all seven sites, SSI was defined according to the CDC definitions published in 
201793.   To meet the definition, an SSI occurs within 90 days after the procedure and involves 
the skin or subcutaneous tissue of the incision or the fascial and muscle layers below the 
subcutaneous layer of the incision. Additional criteria include purulent drainage, positive 
cultures from fluid or tissue, pain or tenderness, localized swelling, erythema, warmth, wound 
dehiscence, fever, tenderness, and/or other evidence of infection (e.g., diagnosed by examination, 
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radiographs, or cultures). If a patient had >1 procedure before an SSI, the infection was attributed 
to the most recent procedure. Patients were monitored for SSI by the treating physicians and 
surgeons as well as perioperative care team. In addition, wound cultures, readmissions after spine 
surgery, and pediatric infectious disease consults were monitored to identify SSIs. The diagnosis 
and documentation of SSIs were made either clinically by physicians using signs such as 
purulent drainage, erythema, pain or tenderness and erythema or by pathogen isolation from an 
aseptically obtained wound specimen.  
 
Statistical Analysis 
The occurrence of SSI within 90 days postoperatively was the binary outcome variable. 
Continuous and categorical variables were dichotomized into clinically meaningful thresholds 
(e.g. age, HGB level, HCT level and WBC count, ASA, hospital volume) (for full details on 
categorization see Appendix 3.1). The range of missing value was 0.1% to 21.9% and the 
missingness did not differ substantially among seven sites. Since there was no evidence that the 
missing data were not random, multiple imputation with 20 iterations was performed to deal with 
some missing values94–96 (Appendix 3.2). Univariable analyses were first conducted to assess the 
relationship between each candidate predictor variable and SSI.  Because many of candidate 
predictor variables could also be correlated with each other, correlation coefficients and variance 
of inflated factors (VIF) was tested for multicollinearity (r>0.80 and/or VIF>10). Parameter 
selection was conducted using logistic regression models based on the results of univariable 
regression (p<0.10) and backward stepwise elimination, which allowed multiple models to be 
developed. Chosen variables were collapsed across adjacent categories to include cell count 
more than 30 to avoid model overfitting.   
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The dataset was randomly split into a training set (80%) and testing set (20%) and five-
fold cross-validation was performed as internal validity testing for each model to reduce 
variability and provide more stable estimates97 (Appendix 3.3). The final model was chosen 
based on discrimination (i.e., how well a prediction model could discriminate patients with and 
without SSI) and calibration (i.e., agreement between observed outcomes and predictions) 
abilities98,99 of testing sets in each model as well as overfitting. The model discrimination was 
assessed by the C-statistic using the receiver operating characteristic (ROC) curve plotting 
sensitivity vs 1-specificity and calculating area under curve (AUC)100. Discrimination slopes 
along with box plots were used to describe absolute difference in average predictions for those 
with and without the SSI101.Lorenz estimates and curves were produced to describe and visualize 
those patients who could be classified as having no SSI without missing many with the SSI102.  
The Hosmer-Lemeshow (HL) goodness-of-fit test was performed for the model 
calibration comparing the observed and predicted probabilities; however, the HL goodness-of-fit 
tests finds smaller deviations to be statistically significant when the sample size is large. 
Therefore, the graphic illustration of the fit was presented by plotting predicted probabilities 
against observed probabilities using calibration plots along with smoothing techniques 
(estimating the observed probabilities of the SSI in relation to the predicted probabilities of 
SSI)103. Calibration slopes reflecting the average effect reductions of predictors to improve the 
calibration of models for new sets of patients104 were developed.  By calculating calibration-in-
the-large, the difference between the average of the observed outcome and the average of the 
predictions105 were also derived.  Overfitting was calculated by in sample error over out sample 
error comparing the average deviances and Pearson residuals of training sets and testing sets.  
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The dominance analysis was performed to determine the relative importance of each risk 
factor in the final model based on contribution to an overall model fit statistic106,107. General 
dominance statistics derived as a weighted average marginal contribution and standardized to be 
out of 100% were reported. The equation to calculate the individual probability of SSI was 
created from coefficients in the final model and a smart phone application for the dynamic risk 
probability calculator was developed for health-care providers to facilitate real time estimation of 
probability of SSI with 95% CI in individual patients. In order to interpret an individual’s 
probability yielded from the calculator application, predicted probability values were charted 
against observed SSI risk in the order of percentile ranking of the probability.  
 
Power Analysis  
A rule of thumb to determine a sample size in developing a prediction model is the events per 
variable (EPV) ratio, defined as the number of outcomes divided by the number of candidate 
predictor variables in the model108,109. The EPV ratio of  >10 is needed to avoid overfitting 109. It 
was anticipated that there would be approximately 4-5% risk of SSI in about 3,000 procedures 
(Appendix 3.4).  Therefore, in order to obtain the EPV >10, it was appropriate to include12-15 
candidate predictor variables in the prediction model. Additionally, in order to compare multiple 
predictive models accepting AUC differences between 0.02-0.03 with baseline AUC 72-84 and 
alpha=0.05, the sample size needed was at least 2,750 procedures (Appendix 3.4).  
 
3.4. Results 
There were 2,720 patients and 3,092 spinal deformity surgical procedures. There were 
237 (8.7%) patients who had more than one surgery (two to eleven). With the following 
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etiologies: 474 (15.3%) congenital or structural, 806 (26.1%) neuromuscular, 284 (9.2%) 
syndromic, 1,511 (48.8%) idiopathic and others 17 (0.6%) (Table 3.1). There were 1,434 
(46.4%) primary instrumentations, 1,220 (39.4%) definitive fusion, 427 (13.8%) 
revisions and 11 (0.4%) others. A total of 132 SSI within 90 days after surgery was 
observed (4.5%) (Table 3.1). In the univariable regression analyses, SSI was associated 
with 20 preoperative patient characteristics: age, gender, height, BMI, etiology, major 
coronal curve, ASA, comorbidities  (pulmonary, behavioral, GI, MSK, neurogenic), HBG 
level, WBC count, G-tube, VP shunt, ambulatory status, diaper dependence, 
hospitalization within 2 years prior to surgery and prior spine surgery. Although height 
was significantly associated with SSI, it was excluded from parameter selection process 
as it was used to calculate BMI.  
 Among surgical factors, type of surgery, surgical approach, pelvic instrumentation, 
number of instrumented levels, type of instrumentation, transfusion, and procedure time were 
associated with SSI. Among hospital characteristics, only volume of spine surgery in the 
institution was associated with SSI. The original data and dataset with multiple imputations gave 





Table 3.1: Descriptive Statistics for candidate predictor variables 
 Descriptive Analyses  Univariable Regression 









Preoperative Patient Characteristics 




















0.63 [0.28; 0.98] <0.001 
Height, mean± SD (range) 144.4±25.0  144.7±25.4  137.6±131.5 -0.01 [-0.02; -0.01] 0.002 
Weight, mean± SD (range) 44.7±20.6  44.8±20.9 43.8±120.7 -0.002 [-0.01; 0.01] 0.597 


















0.49 [0.04; 0.93] 0.032 














0.38 [-0.08; 0.85] 0.107 



































-0.11 [-0.74; 0.52] 0.729 






















0.56 [0.04; 1.08] 0.035 







875 (28.3%)  





0.09 [-3.43; -2.93] 
ref 
0.682 
Sagittal Curve  Hypo/hyper kyphosis 
Normal-kyphosis 
1,512 (48.9%) 












653 (21.1%)  
1,249 (40.4%)  
1,042 (33.7%)  
68 (2.2%)  












1.12 [0.25; 2.00] 
2.19 [1.35; 3.02] 
2.37 [1.20; 3.53] 




























 600 (19.4%)  










232 (7.5%)  














538 (17.4%)  










136 (4.4%)  





-0.13 [-1.04; 0.08] 0.782 
GI Comorbidity Present  
Absent 
390 (12.6%)  










37 (1.2%)  





















442 (14.3%)  










708 (22.9%)  





0.97 [0.61; 1.33] <0.001 
G-Tube Present  
Absent 
368 (11.9%)  





0.87 [0.45; 1.30] <0.001 
VP Shunt Present  
Absent 
102 (3.3%)  










Neural Axis Present  
Absent 
272 (8.8%)  



























1.43 [1.07;1 .78] <0.001 
HGB in g/dl, mean± SD (range) 13.2 ± 1.6  13.2±1.6 13.2±8.4 -0.01[-0.12; 0.10] 0.810 
HGB in g/dl Low :<10  







0.76 [0.01; 1.51] 0.047 








0.53 [0.17; 0.88] 0.004 
HGB in g/dl High >14 







0.41 [0.04; 0.78] 0.030 
HCT in %, mean± SD (range) 39.3 ± 4.3  39.3±4.4 39.4±22.7 0.01 [-0.03; 0.05] 0.668 
HCT in % Low:<31 







0.04 [-0.88; 0.95] 0.934 













HCT in % High: >48 







-0.56 [-2.55; 1.43] 0.580 
WBC in #/ul, mean± SD (range) 7.1 ± 3.2  7.0±3.2 7.9±16.3 0.08 [0.03; 0.13] 0.001 
WBC in #/ul Low: <3.5 
Not Low:  ≥3.5 
232 (7.5%) 





-0.67 [-1.56; 0.23] 0.143 








0.06 [-0.46; 0.58] 0.824 
WBC in #/ul High: >12 







0.62 [0.01; 1.23] 0.046 
Hospitalization 
within 2 years 
Yes  
No  
2,412 (78.0%)  





0.41 [0.02; 0.80] 0.038 
Prior SSI Yes  
No  
2,956 (95.6%)  





0.54 [-0.16; 1.24] 0.129 
Prior Spine SSI Yes  
No  
102 (3.3%)  































0.15 [-0.63; 0.93]  
0.705 
Surgical Factors 

















0.38 [-0.23; 0.78] 





















 2,929 (94.4%)  





























263 (8.5%)  










Instrumented Levels in #, mean± SD 
(range) 











  1.23 [0.88; 1.59] <0.001 
Type of 
Instrumentation 


















 87 (4.4%) 









-1.49 [-3.47; 0.48] 0.138 








0.51 [0.13; 0.89] 0.009 




















Procedure Time in hours, mean ± SD [95% 
CI] 



























































Surgical Volume/Year, mean± SD (range) 73.8 ± 74.0 (1.6; 
220) 
74.4 ± 74.4 [71.8; 
77.1] 






















Seven models were developed and compared for discrimination and calibration abilities 
(Appendix 6). In the final model 9 predictor variables were selected on the basis of their ability 
to predict SSI in 90 days after surgery (Model 3 in Appendix 3.6). These included five patient 
characteristics (BMI overweight/obese, neuromuscular etiology, ASA >2, non-ambulatory status, 
abnormal HGB), three surgical factors (revision surgery, presence of pelvic instrumentation, 
procedure time for ≥7 hours), and one hospital factor (<100 spine surgical case per year per 
institution).  
The final model demonstrated adequate predictive discrimination and calibration abilities 
in the testing sets in the five-fold cross validation (Model 3 in Appendix 3.6).   The majority of 
discrimination and calibration abilities in the final model were among the best among all models. 
The average discrimination values in the training sets and testing sets were AUC: 0.77 [95% CI: 
0.73; 0.82] and 0.76 [95%CI: 0.67; 0.85], the discrimination slope of 0.05 [95% CI: 0.04; 0.06] 
and 0.04 [95% CI: 0.03;0.05], and Lorenz curve: 3.63%, 14.01%, and 37.36% SSI and 3.77%, 
13.85%, and 37.86% at 25%, 50%, and 75% cumulative risk proportions respectively. The 
average calibration abilities in the training and the testing sets were calibration slope: 1.03 and 
0.98, expected/observed ratio of 0.99 and 0.99, calibration-in-the-large of 0.01 and 0.01, H-L 
goodness-of-fit-tests of 0.01 and 0.44 respectively. Overfitting was not observed: deviance of 
0.99 and Pearson residuals of 0.99. Coefficients with 95% confidence intervals (Cis) and odds 
ratios for each predictor in the final prediction model are summarized in Table 3.2.  Table 3.2 
also contains AUC with 95% CI In the relative weight analysis, non-ambulatory status, and 





Table 3.2: Odds ratios and AUC for risk each factor for SSI in the final prediction 
model 










Overweight/obese 0.39 1.48 1.00; 2.19 0.049 53.37, 2.11 49.24; 57.50 
Neuromuscular 
etiology 
0.69 1.99 1.25; 3.16 0.004 66.84, 2.19 62.54; 71.13 
ASA >2 0.26 1.30 -0.79; 2.11 0.300   65.81, 2.11 61.67; 69.95 
Non-ambulatory 
status 
0.62 1.86 2.07; 3.20 0.026 67.66, 2.19 63.36; 71.95 
HGB <10g/dL or 
>14g/dL 
0.32 1.38 0.95; 1.99 0.093 55.53, 2.33 50.97; 60.09 
Revision surgery 0.65 1.92 1.16; 2.97 0.003 55.47, 1.90 51.75; 59.19 
Pelvic 
instrumentation 
0.32 1.38 0.86; 2.18 0.182 64.56, 2.21 60.23; 68.90 
Procedure 
duration ≥7 hours 
0.65 1.92 1.28; 2.88 0.002 63.37, 2.41 58.64; 68.10 
Surgical volume 
<100 









Figure 3.1 Relative importance (%) and accumulative AUC (%) of risk factors for SSI in 




6.51% 4.14% 3.72% 2.88%
67.66% 70.40%
71.31% 71.14% 74.18%





















































































 The equation to calculate the individual probability of SSI is presented in Figure 3.2 and 
the image of the app for the dynamic risk probability calculator is depicted in Figure 3.3. The 
probability for an individual patient yielded from the prediction model via equation or the app 
could be interpreted in the context of the proportionality of patients who would have had SSI if 
they had received that probability value in the testing sets (Table 3.3).  For example, a patient 
who received a probability of 4.2% from the prediction model would have ranked as 70-
percentile probability by the model and approximately one third (31.8%) of SSI was observed 







Figure 3.2 Equation calculating individual probability of SSI 
 
  
[exp [-4.74 + 0.39(overweight/obese)+ 0.69(neuromuscular)+ 
0.26(ASA>2)+ 0.62 (non-ambulatory)+ 0.32(HGB<10g/dL or 
>14g/dL)+ 0.65(revision)+ 0.32(pelvic instrumentation)+ 
0.65(procedure ≥7hours)+ 0.43(surgical volume<100)] 
 
1 + [exp [-4.74 + 0.39(overweight/obese)+ 0.69(neuromuscular)+ 
0.26(ASA>2)+ 0.62 (non-ambulatory)+ 0.32(HGB<10g/dL or 
>14g/dL)+ 0.65(revision)+ 0.32(pelvic instrumentation)+ 










 Figure 3.3 App for the dynamic risk probability calculator producing individual 





Table 3.3: Probability predicted by the final model and observed SSI  
Percentile Ranking of Predicted 
Probability 
Value of Predicted 
Probability 
Cumulative Observed SSI 
0 1.0% 0.0% 
5 1.0% 0.6% 
10 1.0% 1.2% 
15 1.3% 1.5% 
20 1.5% 1.7% 
25 1.5% 3.8% 
30 1.5% 5.9% 
35 1.6% 6.8% 
40 1.8% 9.0% 
45 2.1% 11.0% 
50 2.3% 12.9% 
55 2.6% 18.4% 
60 2.8% 22.0% 
65 3.6% 25.2% 
70 4.2% 31.8% 
75 5.2% 38.6% 
80 6.6% 44.7% 
85 8.4% 56.1% 
90 10.7% 67.9% 










Although SSI is one of the most common causes for hospital readmission among pediatric 
patients undergoing spinal deformity surgery 28,62,63, currently health-care providers are unable to 
accurately identify high-risk patients and provide individually tailored preoperative anticipatory 
counseling and risk mitigation. Identifying high-risk patients makes it possible to target 
resources for preoperative optimization of modifiable risk factors and alert the perioperative care 
team in advance of patients at particularly high risk of SSI.  
 Most patient and surgical characteristics identified as risk factors in our final model were 
consistent with existing literature. Obesity, for example, has been identified as a significant risk 
factor for SSI in a number of studies in pediatric spine surgery 32,73,76,91,110 as well as in other 
pediatric surgical procedures111. Similarly, pediatric patients with neuromuscular 
etiology23,24,32,34,71,73,112, non-ambulatory status32,73,113, or high ASA scores32 been previously 
noted to have increased risk of SSI, as have low preoperative HBG in patients with spina 
bifida114.  Consistent with previous studies, revision surgery23,34, instrumentation to pelvis23,32, 
and longer surgery32  were risk factors in our final prediction model.  
In addition to confirming suspected or known risk factors previous reported, we 
identified other potentially important SSI risk factors in this population.  Surgical volume was an 
important factor in our final prediction model, but previous data are sparse.  To our knowledge, 
the only other study in the field of pediatric spine surgery investigating the association between 
the volume and SSI found that the average volume across hospitals ranged from 8 to 92 
procedures per year and was not associated with 60-day readmissions caused by SSI33. This 
discrepancy may be due to the threshold of the surgical volume (<100 in our study versus 




our study versus 60-day readmissions caused by SSI).  However, a meta-analysis of 11 studies 
with 1,986,545 patients117 and a literature review comprising 9 studies with 954,007 patients118 
among adults undergoing spinal surgery consistently demonstrated that high surgical volume was 
associated with decreased postoperative complications including SSI. This association has also 
been reported in other surgical fileds119–123.  
 The final model achieved adequate discrimination and calibration abilities as 
demonstrated by various measures in the testing sets. The AUC (0.76) in the testing set was 
lower than the AUC in the training set (0.77); however, this is usually the case as the model gets 
fitted in the training set and coefficients determine the training set are used in the testing set. This 
commonly used measure, AUC, reflected that when pairs of patients with and without SSI were 
presented, the model would have provided higher probabilities of SSI to patients with SSI than to 
patients without SSI about three-quarters of the time. Since AUC of 0.76 is fair and not great and 
having a pair of patients with and without SSI can be artificial97, the result provided by Lorenz 
curve became useful to evaluate the discriminative ability of the model. The average Lorenz 
curve in testing sets plotted 3.77%, 13.85%, and 37.86% with SSI against the cumulative 
proportion of 25%, 50%, and 75% of the study subjects ranked by predicted SSI risk 
respectively. This can be interpreted as approximately two thirds of patients with SSI being 
ranked above the 75th percentile by the final prediction model.  
In addition to discrimination, calibration is another crucial property in evaluating 
prediction models. H-L goodness-of-fit-tests (p=0.44) indicated the ability of the final prediction 
model to fit a given testing set. Additionally, calibration-in-the-large (0.01), calibration slope 
(0.98) and expected to observed ratio (0.99) demonstrated that the difference between the 




 This study also addressed several important methodological considerations. First, the 
database was created specifically to investigate SSI and included detailed clinical information 
collected by trained research personnel as opposed to previous prediction models, which have 
used national datasets developed for other reasons. The National Surgical Quality Improvement 
Program (NSQIP) pediatric surgical risk probability calculator used Current Procedural 
Terminology (CPT) codes which were recorded to maximize payer reimbursement and did not 
necessarily include information regarding risks of SSI56.  Another model used the Pediatric 
Health Information System (PHIS) data which included administrative data and billing codes33 
known to have poor correlation with medical records57,58.  
Second, in this study we addressed generalizability of the risk probability calculator in 
several ways. Unlike a prediction model previously published which included patients from just 
a single hospital32, this study included patients from multiple centers in North America.  
Although further external validity studies are needed, the use of 5-fold cross-validation to avoid 
overfitting of the model as well as the use of multi-center data enhances the potential accuracy 
for predicting SSI in future populations.  
Third, in this study we attempted to address limitations of discrimination and calibration 
testing by using methods beyond AUCs and goodness of fit tests. The final model was chosen by 
comparing multiple values, which helped to create the final model function leading to maximum 
discrimination and calibration abilities within the new set of patients. Further, unlike most of the 
previously published prediction models32,33,56, this study utilized the CDC SSI definition which is 
also used by the Centers for Medicare and Medicaid Services to determine penalties for 
infections that occur within 90 days of surgery.  Lastly, the user-friendly graphical interfaces 




The risk probability calculator could enhance counseling and shared decision-making for 
patients and families. In the past decade, there have been national initiatives to promote shared 
decision-making.  One example is the 2007 Washington State legislation incentivizing shared 
decision-making as an alternative to the traditional informed consent process notifying patients 
and their families the decision made by healthcare providers (Washington State Legislature. 
RCW 7.70.060). Spatz and colleagues recommended that decision aids with high quality 
evidence be disseminated and used to support the shared decision-making process60. Based on 
individualized assessment of the probability of SSI from the risk probability calculator, 
alternative approaches such as conservative treatment or delaying surgical treatment may further 
be considered. Quantifying risk of SSI in individual patients is not only imperative for patients’ 
well being but also important to fulfill safety and risk management responsibilities of the 
healthcare system. Rapid shifts in health-care delivery and reimbursement paradigm in the U.S. 
such as penalizing hospitals for unplanned readmission124 challenges health-care providers, 
leaders and systems to improve quality of care as well as to reduce per capita costs125.  Surgical 
site infections in particular call for attention as they are one of the most common causes for 
hospital readmission28,62,63. The ability to calculate the probability of SSI in individual patients 
before surgery allows healthcare providers to optimize perioperative care plan and potentially 
lower the subsequent incidence of SSI.  
A limitation of the study is the potential misclassification of SSI due to misdiagnosis or 
variation in defining SSI across sites. In order to minimize the problem, the CDC standardized 
definitions of SSI were used and sites were encouraged to crosscheck the reported SSI 
information in patient charts with other records.  If the misclassification of SSI was differential it 




type of SSI (i.e., superficial, deep or organ infections) was not available. Therefore, it was not 
possible to identify risk factors or predict the risk for specific types of SSI. Some exposure 
variables such as comorbidities were also prone to misclassification due to variability in 
recording, which could have led to information bias if it were differential. Although multiple 
hospital risk factors were included, unmeasured hospital characteristics could affect the risk of 
SSI. The final model demonstrated the average effect of the model and there may be variation 
among hospitals due to these unmeasured characteristics. Future research should examine such 
variations among hospitals. Additionally, the clinical usefulness of the developed risk probability 
model is currently unknown. A next step would be to determine thresholds based on costs and 
benefits to evaluate the model’s performance in terms of classifying patients with or without an 
SSI.  Finally, although efforts were made to avoid overfitting and demonstrate internal 
validation, all complex prediction modeling has the possibility of overfitting which could be a 
threat to generalizability.  Therefore, an important next step is to conduct external validation of 
the risk probability calculator with new sets of patients including those who underwent surgery 
recently or from other hospitals.  
In summary, this study represents the first attempt to develop a risk probability calculator 
for SSI following spinal surgery in children. The calculator contributes to the field by providing 
a tool in clinical practice to enhance patient education and shared decision making, to identify 
high-risk patients preoperatively and to tailor optimized care in order to improve outcomes of 
surgery for individual patients. Future testing is needed to assess the potential contributions to 




Chapter 4: Preventive Strategies Reducing Individuals’ Risk of 
Surgical Site Infection within 90 Days Following Pediatric 




Despite ongoing efforts to create guidelines or demonstrate effective strategies for the 
prevention of surgical site infections (SSI), their multi-factorial nature presents challenges to 
identify the most beneficial preventive strategies for individual patients with different clinical 
and surgical characteristics. The purpose of this study was to investigate the association between 
preventive care measures and patient risk of SSI. This study also aimed to estimate the reduction 
of SSI probability in individual patients by these preventive care measures.  
 
Methods 
Data from patients (0-21 years of age) with spinal deformity who underwent primary, revision, 
and definitive spinal fusion in 7 institutions between 2004 and 2018 were analyzed. Preventive 
care factors examined included the use of topical vancomycin in the operative site and/or bone 
graft, povidone-iodine irrigations, multilayered closure, impermeable dressing, the enrollment in 
Children’s Hospitals’ Solutions for Patient Safety (SPS) program or in the Comprehensive Unit-
based Safety Program (CUSP), and adherence to antibiotic prophylaxis.  The Centers for Disease 




odds ratios of SSI for each of these preventive care factors were calculated and five-fold cross 
validation was utilized to examine predictive abilities of the final model.  
 
Results 
There were 3,092 spinal deformity surgeries and 132 SSI (4.5% ranging from 0% 5.3%) in this 
study.  Patients in sites enrolled in CUSP/SPS had a 51.7% decrease in SSI (odds ratio: 0.48, 
[95% CI: 0.29; 0.82]) compared to those not enrolled. The model just including the CUSP/SPS 
was 56.02% [95% CI: 52.71; 59.33]. The final model demonstrated adequate discriminative (i.e., 
area under the curve [AUC]: 0.77) and calibrative (H-L goodness-of-fit-tests of 0.21) abilities. 
 
Conclusions 
The result of this study allows us to calculate the effects of institutional participation in 
quality improvement programs and the use of providone iodine irrigations in reducing SSI in 
individual patients with different preoperative characteristics receiving various surgical care at 












Several guidelines for the prevention of surgical site infection (SSI) have been developed by the 
Centers for Disease Control and Prevention (CDC)86,87 and other agencies88–90 in the United 
States. In the field of pediatric spinal deformity care, best practice guidelines for the prevention 
of SSI were developed based on expert consensus126,127. There are ongoing efforts to build 
evidence in the field, and a review of recent literature reported that the use of antibiotic 
prophylaxis regimens such as gentamicin-impregnated allograft bone and intra-wound 
vancomycin powder could be effective in decreasing risk of SSI35,75. However, the complex 
multi-factorial nature of SSI imposes difficulty to identify which individual patients will best 
benefit from implementation of specific preventive care factors.  Assuring that patients, 
particularly those at highest risk, receive appropriate and targeted preventive care is important, 
particularly in the value-based model of simultaneously increasing quality of care and improving 
population health while also decreasing per capita costs125.  
We have developed and tested SSI risk to compute a probability of SSI in individual 
pediatric patients undergoing spine surgery using patient, surgical and hospital factors which are 
determined and planned preoperatively and unlikely be modified (Chapter 3). This calculator 
makes it possible to identify high-risk patients, enhance patient education and shared decision 
making, target resources for preoperative optimization, and alert the perioperative care team in 
advance. An essential next step is to identify modifiable preventive care measures to reduce the 
individual patients’ probability of SSI.  Purposes of this study were to investigate the association 
between preventive care measures and patient risk of SSI, and to estimate the reduction of SSI 
probability by these preventive care measures from the baseline probability in individual patients 




preventive care factors would be associated with reduced incidences of SSI within 90 days after 
spinal surgery in individual patients.   
 
4.3. Materials and Methods 
As described in Chapter 3, this was a multi-center retrospective study using data from seven 
institutions in urban hospitals with a broad range in number of surgical procedures (mean=515, 
range=8 to 1,490). Upon IRB approval at each site, pediatric patients (0-21 years of age) with 
spinal deformity who underwent primary, revision, and definitive spinal fusion between 2004 
and 2018 and underwent standard perioperative care were included. Trained research personnel 
at each site reviewed patient charts, and a final audit was conducted by the first author to identify 
discrepancies or ambiguities in the data.  Additional chart reviews were requested at each site for 
clarity to ensure the quality of the data. The unit of analysis was procedures instead of patients as 
some patients had more than one procedure and these procedures were different in terms of 
invasiveness.  
Preventive care factors included the use of topical vancomycin in the operative site 
and/or bone graft, povidone-iodine irrigations, multilayered closure, or impermeable dressing, 
the enrollment in Children’s Hospitals’ Solutions for Patient Safety (SPS) program 128 or in the 
Comprehensive Unit-based Safety Program (CUSP)129 (Appendix 4.1), and adherence to the 
institutional perioperative antibiotic prophylaxis guideline (Appendix 4.2). Multilayered closure 
involved the development of myocutaneous flaps and closure of the deep muscles to help 
obliterate the peri-instrumentation dead space and relieves tension. The impermeable dressings 
were waterproof and impermeable to bacteria and contaminants such as medical skin adhesive 




The CUSP was designed to prevent patient harms including healthcare-associated 
infections (HAIs) by facilitating improvements in safety culture, teamwork, and communication 
using a checklist of evidence-based practices. The SPS was designed to create a safe and healing 
environment for children in need for care by employing the cultural transformation strategies 
focusing on in-depth evaluation and change in communication, team dynamics and leadership. 
Data regarding adherence to the institutional perioperative antibiotic prophylaxis guideline were 
collected but were available only in one of participating institution. Adherence to the institutional 
perioperative antibiotic prophylaxis guideline were categorized into incorrect or correct in 
administration of preoperative, intraoperative or postoperative dosing or timing (Appendix 4.2).  
Patients with suspected infections before surgery who were continued on antibiotics >24 hours 
after surgery were not categorized as receiving incorrect perioperative prophylaxis.  
As described in Chapter 3, data collectors used the Centers for Disease Control and 
Prevention (CDC) definition of SSI published in 201793 describing SSI as occurring within 90 
days after the procedure and involving the skin or subcutaneous tissue of the incision or the 
fascial and muscle layers below the subcutaneous layer of the incision. In each setting the 
treating physicians and surgeons as well as perioperative care team and pediatric infectious 
disease consults were responsible for closely monitoring wound cultures and readmissions after 
spine surgery to diagnose and document the occurrence of SSI. If a patient had more than one 
procedure before an SSI occurrence, the SSI was attributed to the most recent procedure. 
 
Power Analysis   
An a priori power was conducted to compare the risk of SSI between patients who received each 




significance level of 5%, more than 90% power would be achieved to detect absolute difference 
of 2% in AUC. To ensure adequate power to add a care factor in the previously developed risk 
calculator using prediction modeling, the events per variable (EPV) ratio, defined as the number 
of outcomes divided by the number of risk factors in the model, for more than 10 was sought 
for108,109. There were 3,092 procedures and 132 SSI (4.5%) in the database. Therefore, the 
prediction model up to 13 predictors was adequate to be entered in the prediction modeling at a 
time. There were ten patient, surgical and hospital factors already determined; therefore, it was 
appropriate to include up to three preventive care factors in the final prediction model.  
 
Statistical Analysis 
Missing data in preventive care factors (2.2%-8.9%) were addressed using multiple imputation 
since there was no evidence that the missing data were not random94–96 (Appendix 4.3). Simple 
logistic regression models were first utilized for each preventive care factor to examine its 
association with the SSI. Significant preventive care factors in the univariable analyses (p<0.05) 
and patient, surgical and hospital factors identified in the risk calculator as significant were 
included: overweight/obese, neuromuscular etiology of the spinal deformity, American Society 
of Anesthesiologist Physical Status Classification System (ASA) >2, non-ambulatory status, 
abnormal hemoglobin (HGB) level, revision surgery, presence of pelvic instrumentation, 
procedure time ≥7 hours and 100 spine surgical case per year per institution. The corresponding 
odds ratio (OR) of SSI in the multiple logistic regression model was obtained for each preventive 
care factor.  
The data were randomly split into training (80%) and testing (20%) cohorts, and five-fold 




under curves (AUC) plotting sensitivity vs 1-specificity and calculating were calculated to 
evaluate the model discrimination, ability to discriminate patients with and without SSI100. 
Discrimination abilities were further assessed by discrimination slopes and box plots comparing 
average prediction differences in those with and without the observed SSI101, and Lorenz 
estimates and curves depicting cumulative proportion of patients ranked by predicted probability 
against the cumulative proportion of patients with SSI102. The model calibration was assessed by 
the Hosmer-Lemeshow (HL) goodness-of-fit test along with the graphic illustration of the fit 
using calibration plots103. Calibration slopes104, and calibration-in-the-large105 were also 
evaluated. Overfitting was calculated by in sample error over out sample error comparing the 
average deviances and Pearson residuals of training sets and testing sets. In order to calculate the 
individual probability of SSI, a risk prediction algorithm was created from coefficients in the 
final model. Additionally, a smart phone application for the dynamic calculator was developed to 
facilitate use in clinical setting.  
 
4.4       Results 
There were 3,092 spinal deformity surgical procedures, and a total of 132 SSI within 90 days 
after surgery were reported (4.5%). Multilayered closure was performed in approximately half of 
patients followed by topical vancomycin in approximately 40% of patients, povidone-iodine 
irrigations and enrollment in CUSP/SPS program in about one fourth of patients and 
impermeable dressing in approximately 15% of patients (Table 4.1). For the institution with 
available data regarding adherence to their perioperative antibiotic prophylaxis guideline, there 
were 1,487 surgical procedures and 57 SSI (3.8%) (Table 4.2). Reported adherence to 




was the highest (91.5%). Adherence to preoperative and intraoperative dosing and timing was 
similar, ranging from 87% to 89.5%.  Univariable regression analyses demonstrated that the use 
of povidone-iodine irrigations and enrollment in the CUSP or SPS programs were associated 
with a decreased risk of SSI. When the CUSP/SPS enrollment alone was in the model, patients 
whose procedures were performed when sites were enrolled in the programs had 49.4% decrease 






Table 4.1: Descriptive statistics for preventive care factors in all patients 
 
 Descriptive Analyses  Univariable Regression 








































 53 (3.6%) 
0.31[-0.04; 0 .67] 0.086 


























Table 4.2: Descriptive statistics for adherence to IV antibiotics in the subgroup  
 
 Descriptive Analyses  Univariable Regression 






Coefficient [95% CI] p value 








0.21 [-0.71; 1.14] 0.666 

























































 The final model including povidone-iodine irrigations and the enrollment in CUSP or 
SPS as well as the previously identified patient, surgical and hospital characteristics 
demonstrated adequate predictive discrimination and calibration abilities in the training and 
testing sets (Appendix 4.4).   The average discrimination abilities of this model in the training 
and the testing sets were AUC: 0.78 [95% CI: 0.74; 0.83] and 0.77 [95% CI:0.69; 0.85], the 
discrimination slope of 0.05 [95% CI: 0.04; 0.06] and 0.05 [95% CI: 0.03;0.06], and Lorenz 
curve: 2.81%, 12.87%, and 35.65% and 3.52%, 12.19%, and 39.37% at 25%, 50%, and 75% 
cumulative risk proportions respectively. The average calibration abilities were calibration slope: 
1.03 and 0.97, expected/observed ratio: 0.99 and 0.99, calibration-in-the-large: 0.01 and 0.01, H-
L goodness-of-fit-tests of 0.002 and 0.16. Overfitting was not observed: deviance of 0.99 and 
Pearson residuals of 0.99. Coefficient and odds ratios with 95% confidence intervals (Cis) for 
preventive care factors in the final prediction model are presented in Table 4.3. Patients from 
institutions enrolled in the CUSP/SPS programs had an average 48.9% lower in SSI compared 
with patients from non-enrolled sites (odds ratio: 0.51, [95% CI: 0.30; 0.86], p=0.01). Although 
not statistically significant, patients who received povidone-iodine irrigations had an 
average18.3% decrease in SSI compared with patients without the irrigations (odds ratio: 0.81, 




Table 4.3: Odds ratio and coefficients for SSI in the final prediction model 
 Coefficient Odds ratio 95% Confidence 
Interval 
p value 
Overweight/obese 0.40 1.49 1.00; 2.20 0.048 
Neuromuscular etiology 0.51 1.67 1.19; 2.74 0.043 
ASA >2 0.34 1.40 0.86; 2.30 0.179 
Non-ambulatory status 0.66 1.93 1.11; 3.35 0.020 
HGB <10g/dL or >14g/dL 0.31 1.36 0.94; 1.98 0.106 
Revision surgery 0.70 2.01 1.29; 3.12 0.002 
Pelvic instrumentation 0.39 1.48 0.92; 2.35 0.106 
Procedure duration ≥7 hours 0.66 1.93 1.28; 2.90 0.002 
Surgical volume <100 0.18 1.20 0.74; 1.94 0.473 
Povidone-iodine irrigations -0.21 0.81 0.44; 1.48 0.494 







The equation and the smartphone application to calculate the reduction of the predicted risk of 
SSI in individual patients from the final model are presented in Figures 4.1 and 4.2 respectively. 
Some likely cases are described in Table 4.4. For example, in Case 2, the predicted risk of SSI in 
patients with neuromuscular etiology, ASA=2 and non-ambulatory status who underwent pelvic 
instrumentation and had ≥7 surgical procedure was reduced from 13.4% to 11.1% with 








Figure 4.1: Equation calculating the reduction of individual probability of SSI by 
preventive care factors 
 
  
exp [-4.42 + 0.40(overweight/obese) + 0.51 (neuromuscular) + 0.34 (ASA>2) + 
0.66 (non-ambulatory) + 0.31 (HGB<10g/dL or >14g/dL) + 0.70 (revision) + 
0.39 (pelvic instrumentation) + 0.66 (procedure ≥7 hours) + 0.18 (surgical 
volume<100) -0.21 (povidone-iodine irrigations) - 0.67 (CUSP/SPS 
enrollment)] 
 
1 + exp [-4.42 + 0.40(overweight/obese) + 0.51 (neuromuscular) + 0.34 
(ASA>2) + 0.66 (non-ambulatory) + 0.31 (HGB<10g/dL or >14g/dL) + 0.70 
(revision) + 0.39 (pelvic instrumentation) + 0.66 (procedure ≥7 hours) + 0.18 












Figure 4.2: App for the dynamic risk calculator producing reduction of individual 
probabilities of SSI by preventive care factor
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Table 4.4. Predicted risk of SSI with preventive strategies 
Factors Case 1 Case 2 Case 3 
BMI overweight/obese   X 
Neuromuscular Etiology X X  
ASA >2 X X  
Non-ambulatory X X  
HGB <10g/dL or >14g/dL X   
Revision surgery    
Pelvic instrumentation X X  
Procedure duration ≥7 hours X X X 
Surgical volume <100 X  X 
 
Predicted risk of SSI 20.1% 13.4% 4.0% 
 
Predicted risk of SSI with povidone-iodine irrigations 16.9% 11.1% 3.2% 
Predicted risk of SSI with CUSP/SPS enrollment 11.4% 7.3% 2.1% 
Predicted risk of SSI with both povidone-iodine irrigations 
and CUSP/SPS enrollment 
9.4% 6.0% 1.7% 
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4.5. Discussion 
The goal of this study was to identify preventive care factors associated with a reduction in 
incidences of SSI within 90 days after surgery in pediatric patients with spinal deformity. The 
risk calculator previously developed using prediction modeling identified the probability of SSI 
in individual patients based on preoperative factors (e.g., etiology and ambulatory status) and 
intraoperative factors (e.g., instrumentation to pelvis and surgical time), which are determined 
and planned preoperatively and unlikely to be modified in many cases. In this study we 
attempted to identify modifiable preventive care factors, which could be employed in the real-
world clinical setting.  
This study demonstrated that the enrollment in CUSP or SPS was significantly associated 
with a reduced risk of SSI. Both CUSP and SPS, focusing on teamwork, communication and 
leadership, were designed to prevent patient harms and to create safe environment by facilitating 
organizational improvements and employing the cultural transformation. This finding was 
consistent with existing literature reporting the benefit of CUSP and SPS in reducing SSI in 
various surgical specialties among both adult and pediatric populations130–133. This suggests that 
the socio-adaptive aspects of care were especially important in reducing the risk of SSI. Quality 
improvement requires orchestrated efforts including robust leadership and commitment of the 
entire care team along with an understanding of health care delivery and human behavior134,135. 
Hence, reviewing and investing in socio-adaptive aspects of care delivery may be one crucial 
step along with seeking other technical approaches.  
On the technical side, this study showed that povidone-iodine irrigations might have been 
associated with a reduced risk of SSI although results were not uniformly statistically significant.  
Although it was not statistically significant on average, the calculated probability of SSI at the 
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individual level produced by the equation was still reduced when providone-iodine irrigations 
were performed. The impact of the povidone-iodine irrigations found in our study was not as 
great as in a previous study reporting an approximately 20 percent reduction136. This may be due 
to the fact that our sample size was too small, or the previous study only included patients with 
adolescent idiopathic scoliosis (AIS) while this study had patients with AIS as well as younger 
patients and patients with more involved etiologies and complex comorbidities.   
This study is important in several ways. First, identifying potentially modifiable 
preventive care factors is valuable in the clinical setting. Although it is not possible to modify a 
number of risk factors such as the neuromuscular etiology of spinal deformity, by intervening on 
modifiable factors, incidence of SSI could be reduced. Targeting preventive care strategies for 
children undergoing surgery for spinal deformities, and specifically focused those identified to 
be at the highest risk for SSI, is important.  This is true particularly when the goal is to achieve 
simultaneous improvements in the quality of care while at the same time decreasing per capita 
costs125. Second, results of this study can provide insights into potential causal mechanisms of 
SSI.  Although risk prediction and investigation of causal inference differ in principle and 
methodology, prediction modeling identifies exposures significantly associated with outcomes. 
Therefore, preventive care factors identified in this study warrant further study to advance our 
understanding of potential strategies to reduce SSI. Third, this study defined SSI using the 
standardized CDC definition which is also used by Center for Medicare and Medicaid Services 
(CMS) to determine penalties for surgical readmission (within 90-days after surgery).  
There were several limitations in this study. First, misdiagnosis or variations in defining 
SSI might have occurred across sites as SSI ranged from 0% to 5.3%. Although each site agreed 
to use the CDC standardized definitions of SSI and was asked to validate the SSI data in patient 
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charts with other records, the accuracy of the data was dependent on research personnel at each 
site. Second, an SSI could have been treated at a site not contributing to the database and not 
reported to a performing surgeon. However, this was unlikely due to the seriousness of spinal 
surgery and SSI. Next, some preventive care factors may have been misclassified or not 
recorded.  If recording errors of the outcome (SSI) and/or the exposures were differential, 
information bias and inaccurate prediction are possible.  An important next step in the research is 
to validate the reduction effect of preventive care factors tested in this study in multiple data sets 
across different times and settings. Finally, the CUSP and SPS programs are specific to the 
United States and may not be generalizable to other countries. These programs focus on the 
socio-adaptive aspects of care management, facilitated organizational improvements and cultural 
transformation, but these approaches may not be appropriate in different cultures and customs. 
Therefore, future studies which investigate causal pathway (mediator effects) between these 
quality programs and the decreased risk of SSI are needed to identify potential interventions in 
place of culturally specific programs to improve human behavior and reduce the risk of SSI on 
other countries. 
In conclusion, this study presents the first-time evaluation of the potential effects of 
preventive care factors on SSI risk in individual patients and taking into account individual 
patients’ baseline characteristics and predetermined surgical and hospital factors which would be 
difficult to modify but could confound the results. The final model encompassing preventive care 
factors and patient, surgical and hospital factors has adequate predictive accuracy for 90-day SSI 
after surgery in pediatric patients with spinal deformity. The results of this study add new 
information to enhance personalized care in clinical practice by identifying factors, which could 
reduce the risk of SSI for specific patients.  
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Chapter 5: Dissertation Summary and Conclusions 
 
5.1. Summary of Findings, Discussion of Conclusions and Recommendations  
This dissertation sought to advance understanding of risk factors for surgical site infection (SSI) 
in pediatric patients undergoing spinal deformity surgery and to add knowledge on preventive 
strategies to reduce the risk of SSI in this population. In order to meet these goals, three studies 
were conducted. The first study was a systematic review and the meta-analysis formally 
aggregating and evaluating current studies investigating associations between SSI and its risk 
factors as well as its preventive strategies. The second study describes the development and 
testing of risk probability calculator by prediction modeling to assess the probability of SSI in 
individual patients from potential risk factors present or determined when patients were 
scheduled to have spine surgery. The last study was a retrospective cohort study investigating 
associations between preventive strategies and the reduction of SSI and developing a prediction 
model to identify effective strategies to reduce the probability of SSI in individual patients. The 
last study utilized the same cohort but built off the prediction model from the second study. A 
long-term goal of these studies in this dissertation was to have an impact in the field by 
providing information in clinical practice to enhance personalized care and improve outcomes of 
surgery in each patient. 
 The aim of Chapter 2 in this dissertation was to conduct a systematic review and a meta-
analysis to assess published literature investigating associations between various risk factors 
and SSI in pediatric patients undergoing spine surgery.  In this review, the Preferred Reporting 
Items for Systematic review and Meta-Analysis (PRISMA-P)64 was utilized. A total of 763 
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papers were identified using PubMed and Ovid in existing peer-reviewed studies in English 
published from January 2000 through April 2019.  Thirteen studies met the inclusion criteria 
after abstract or full manuscript review. The inclusion criteria were papers with pediatric 
population (age 0-21 years) with spinal deformity undergoing any surgical procedures in North 
America. Full manuscripts needed to be available with investigations on SSI (despite the 
definition of SSI) as a primary outcome along with its risk factors.  
 Seven studies were rated as average and six as poor quality based on a quality checklist. 
The meta-analysis demonstrated that the risk of SSI increased by the following factors: 
overweight to obese, neuromuscular etiology, gastrostomy tube, non-ambulatory status, pelvic 
instrumentation, and greater estimated blood loss. There were inconsistencies regarding other 
factors possibly due to differences in host population in terms of age and etiology, type or year of 
surgical procedure and/or definition of SSI.  
 The results of this literature review highlighted the limitation in our ability to determine 
risk factors and effective interventions for SSI. This limitation is likely due to small number of 
studies for each risk factor and quality of each study reviewed or lack of single study which 
includes comprehensive set of both risk and preventive factors like this study. Prominent 
problems in reviewed papers included inadequate confounder controls such as lack of concrete 
hypothesis, lack of data on potential confounders, and inappropriate statistical analyses of 
confounder adjustments. Thus, more rigorous methodology is recommended in future studies 
including development of testable hypotheses identifying primary exposures of interests, 
consideration of possible confounders and adequate use of statistical analysis for adjustments and 
stratifications. The inconsistent definitions of SSI among the studies was also problematic. The 
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use of a common SSI definition such as the Centers for Disease Control and Prevention (CDC) 
criteria93 for ease of interpretation and to build strong evidence is warranted for future studies.  
The aim of the study summarized in Chapter 3 was to create a calculator using 
prediction modeling including patient, surgical and hospital characteristics to quantify the risk 
of SSI in individual patients. The study was a retrospective cohort study on pediatric patients (0-
21 years of age) who underwent primary, revision, and final spinal fusion for their spinal 
deformity in one of seven facilities between 2004 and 2018. Candidate risk factors examined 
included 31 patient characteristics, 12 surgical factors and 4 hospital factors, which were present 
or determined at preoperative planning and not usually modifiable.  Data collectors at each site 
used the CDC criteria93 which defined SSI as occurring within 90 days after the procedure and 
involving the skin or subcutaneous tissue of the incision or the fascial and muscle layers below 
the subcutaneous layer of the incision137,138.  Various discrimination and calibration testing 
methods were used to evaluate predictive abilities of models using five-fold cross-validations by 
randomly splitting dataset into training sets (80%) and testing sets (20%).  
 There were 3,092 spinal deformity surgical procedures with a total of 132 SSI, which 
occurred within 90 days after surgery (4.5%). Seven prediction models were initially developed 
and compared for their predictive abilities. In the final model, nine risk factors were selected on 
the basis of their ability to predict SSI: overweight/obese, neuromuscular etiology, American 
Society of Anesthesiologists’ (ASA) physical status classification system >2, non-ambulatory 
status, abnormal hemoglobin (HGB) level, revision surgery, presence of pelvic instrumentation, 
procedure time for ≥7 hours, and <100 spine surgical case per year per institution. The final 
model demonstrated adequate predictive discrimination and calibration abilities. In the relative 
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weight analysis, non-ambulatory status and neuromuscular etiology were the major factors of 
SSI in the prediction model.  
Most of the patient and surgical risk factors identified in the final model were consistent 
with existing literature. Low surgical volume, on the other hand, had not been demonstrated in 
previous pediatric spinal surgery study33 but found to be an important factor for the increased 
risk of SSI in this study. This discrepancy between these studies may be due to the difference in 
threshold of the surgical volume or the definition of the SSI.  Since studies in adults have 
consistently demonstrated that low surgical volume was associated with increased risk of SSI117–
123, more studies need to be conducted in the field of pediatric spine surgery to investigate this 
association with careful consideration of surgical volume thresholds and SSI definitions.    
Since a major objective of this program of research was to provide information for 
health-care providers to enhance personalized care and improve surgical outcomes in patients, a 
next step would be to evaluate the clinical usefulness of the model by establishing a decision 
threshold which accurately classifies patients as having an SSI when above and not having an 
SSI when below the threshold. This cutoff would be formally defined by the decision-analytic 
approach weighting harms versus benefits97.  The clinical usefulness of the developed model 
would then been evaluated in terms of model’s ability to classify patients better than a default 
clinical practice without the prediction model.  
In order to enhance generalizability of the prediction model developed in Chapter 3, both 
internal and external validation is essential.  Great efforts were made in this study to establish 
internal validity and avoid overfitting by performing 5-fold cross-validations. While internal 
validity confirms the quality of the prediction model as developed within a specific setting, 
external validity may vary, based on characteristics of the population to which the model is 
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applied97.  External validity needs to address temporal, geographical, methodological and 
spectrum transportability139. Therefore, future studies must be conducted with populations 
composed of recent surgical patients, from other hospitals, regions or countries, with data 
collected by methods other than patient charts such as claims data, and with longer follow-up in 
terms of SSI occurrence. Future studies examining external validation of the risk probability 
calculator using entirely new datasets will enhance confidence regarding the relevance of the 
developed calculator across clinical settings.  
The aim of the study summarized in Chapter 4 of this dissertation was to investigate the 
association between preventive care measures and SSI and predict the reduction of SSI 
probability in individual patients by these preventive strategies. There are ongoing efforts to 
develop guidelines for the prevention of SSI86–90 including recommendations based on expert 
consensus in the field of pediatric spinal deformity care126,127. However, SSI is multi-factorial 
and it is difficult to understand what preventive strategies would benefit which individual 
patients. In Chapter 4 the author sought to investigate the association between preventive 
strategies commonly used in the United States and patient risk of SSI and to estimate the effect 
of these preventive care measures in reducing the probability of SSI when taking into account 
previously identified risk factors identified in Chapter 3.   
In Chapter 4, the same database was utilized as Chapter 3 and six preventive strategies 
were examined: adherence to the institutional perioperative antibiotic prophylaxis guideline, use 
of topical vancomycin, povidone-iodine soak, multilayer closure, impermeable dressing, and 
enrollment in Children’s Hospitals’ Solutions for Patient Safety (SPS) or in Comprehensive 
Unit-based Safety Program (CUSP).  The CUSP/SPS enrollment and the use of povidone-iodine 
irrigations along with nine risk factors identified in Chapter 3 were entered and fitted in the 
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multiple logistic regression model. Among patients whose procedures were performed at sites 
enrolled in the CUSP/SPS, there was an average 48.9% decrease in SSI. The final model had 
adequate discriminative and calibrative abilities in testing sets. 
The result of this study highlights the importance of reviewing and investing in socio-
adaptive aspects of SSI prevention.  Prevention strategies such as the use of antibiotic 
prophylaxis must be appropriately implemented in clinical settings, and one of the important 
ways in which the perioperative care team plays vital role in SSI prevention is assuring 
adherence to such practices130–133. Given the fact that the occurrence of SSI involves 
multidimensional mechanisms at all levels, careful and diligent orchestrated efforts are naturally 
required in its prevention. This study underscores the importance of human behavior and 
organizational culture in prevention of SSI. Future studies can further investigate to understand 
the association between enrollment in or adaptation of these quality programs and the decreased 
risk of SSI in causal inference modeling controlling for confounders as well as to understand 
causal pathway by which this may occur, i.e. mediator effects.  By investigating mediators, 
effective interventions in place of culture dependent programs could be identified and applied to 
improve human behaviors and reduce the risk of SSI in other countries.  
The risk probability calculator described in Chapter 3 was developed to identify the 
probability of SSI in individual patients based on risk factors present or decided upon during the 
preoperative period, which were primarily not modifiable. These risk factors include patient, 
surgical and hospital characteristics that can be readily identified and recorded for most patients; 
therefore, the risk probability calculator could be of use globally.  On the other hand, preventive 
strategies investigated in the study described in Chapter 4 may not be generalizable to locations 
outside the United States. For example, two programs specific to the United States focused on 
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the socio-adaptive aspects of care management including teamwork, communication and 
leadership and facilitating organizational improvements and employing the cultural 
transformation, but their approaches may not be appropriate in other countries with different 
cultures and customs. Therefore, the separate model was created in Chapter 4 investigating 
commonly used preventive strategies in the United States, which may not be relevant outside this 
country as opposed to the model in Chapter 3 which included variables such as BMI, and 
etiology of the spinal deformity that can be obtained and are relevant across cultures.  
 It is important to note that the finding in this dissertation should be considered in view of 
limitations. First, the CDC standardized definitions of SSI were used, and sites were encouraged 
to validate the reported SSI rates; however, misclassification of SSI may have occurred due to 
misdiagnosis or variation in defining SSI across sites. Additionally, SSI could have been 
diagnosed at another facility and not reported to the surgeon who performed the spinal deformity 
surgery and participated in this study. However, patients are unlikely to seek care in another 
hospital due to the specialized and invasive nature of pediatric spinal deformity surgery and 
management of subsequent SSI. Unfortunately, there was no way to validate the 
misclassification of SSI with the available data. If the misclassification of SSI was differential it 
could have led to information bias. For example, patients with idiopathic etiology of spinal 
deformity are likely to be healthier than patients with non-idiopathic etiologies.  If more patients 
with an idiopathic etiology of their deformity received postoperative care at local hospitals, their 
SSIs may have been under-reported in the database. This scenario would have led the finding of 
an association between idiopathic etiology and SSI, which would be biased toward the null due 
to misclassification. Some exposure variables such as comorbidities may also be prone to 
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misclassification if staff at some hospitals were more thorough in examination and 
documentation.  
 There were also important predictor variables collected but not utilized due to a large 
number of missing values such as estimated blood loss and steroid use. In Chapter 2, the 
systematic review and the meta-analysis demonstrated that greater estimated blood loss was 
associated with increased risk of SSI. The estimated blood loss could have impact on SSI risk in 
individuals and would have improved the predictive ability of final models. However, it is likely 
that these factors would be difficult to obtain, and therefore including them in the model would 
have reduced the ease of use of the risk probability calculator.   
   
5.2. The Contribution to Clinical Practice and to Public Health 
Despite the limitations, studies in this dissertation make several contributions to clinical practice 
in the field of spinal surgery and more generally to public health. First, in Chapter 2, formal 
methodology was used to identify and evaluate published literature investigating associations 
between SSI and risk factors or preventive strategies. Existing reviews had methodological 
issues by aggregating papers without rigorous screening of study populations and formal 
evaluations of quality of papers.  The systematic review and the meta-analysis summarized in 
Chapter 2 was the first in the field of pediatric spinal deformity surgery to formally evaluate risk 
factors for SSI.  
 Second, while previous prediction models have used national datasets developed for other 
purposes, the studies summarized in Chapters 3 and 4 utilized a database created specifically to 
investigate SSI defined by the CDC, which included detailed clinical information collected by 
trained research personnel. Kraemer et al. developed a model predicting complications including 
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SSI within 30 days of discharge in all surgical specialties using the American College of 
Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) Pediatric database56. 
McLeod et al. used the Pediatric Health Information System (PHIS), an administrative database 
created for the purpose of reimbursements to develop a model to predict SSI within 60 days of 
discharge in patients with spinal deformity which included only those of neuromuscular 
etiology33. Both of these models used Current Procedural Terminology (CPT) codes, which are 
designed to maximize payer reimbursement and exclude potentially important risk factors such 
as type of surgery. Croft et al. developed a prediction model for SSI occurring within one year 
after the surgery in patients undergoing spinal fusion surgery only32. Although more granular 
clinical information was included in this study, the generalizability of Croft’s model may be 
limited, as the database only included patients from a single hospital.  
 Third, this dissertation using prediction models would potentially improve quality of care 
and treatment outcomes. The SSI risk probability calculator developed and validated as 
summarized in Chapters 3 and 4 can shift the current clinical practice paradigm by informing 
healthcare providers about high-risk patients and the possible action steps to reduce the risk of 
SSI in individuals in perioperative care. In the preoperative stage, the risk probability score can 
be used to target resources for preoperative optimization, provide alerts to the perioperative care 
team in advance and assemble champions from different disciplines to form the best care team. 
From public health perspective, this study informs health care system that investments to 
improve socio-behavioral properties in the organization may contribute to the efficient 
improvement in treatment outcomes. In the long term, the investment in such programs may 
contribute to the efficient reduction in SSI and burden to patients, families, and health care 
system. 
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 Fourth, the risk probability calculator developed in this study can make contribution by 
enhancing informed counseling and facilitating shared decision-making with patients and 
families. In preoperative planning, the prediction model can yield multiple probabilities of SSI in 
an individual patient with different surgical scenarios to weigh risks and benefits of various 
interventions. Based on such individualized assessment, approaches such as delaying surgical 
treatment to optimize BMI or hemoglobin levels could be discussed with patients and families. 
Shared decision-making is important from public health perspective as well. In the past decade, 
there have been national initiatives to promote shared decision making such as 2007 Washington 
State legislation incentivizing shared decision-making as an alternative to the traditional 
informed consent process notifying patients of the decision made by physicians60.  
Fifth, risk probability scoring could be used as a tool for risk adjustment. The Centers for 
Medicare & Medicaid Services (CMS) use incidence of readmission as a publicly reported 
quality metric and plan to decrease reimbursement to hospitals with high incidence of 
readmission61. However, if reimbursements are based on the incidence of readmission alone and 
are not adjusted for patient-specific risk, there may be disincentives for a hospital to provide 
services to high-risk patients. SSI is one of the most common causes for hospital 
readmission28,62,63 and risk prediction models for SSI can be a useful risk adjustment tool to 
calculate incidence of readmission with standardized risk. This risk-standardized readmission 
then can be used for hospital comparison, public reporting, and reimbursement determinations in 
fair manner with respect to quality of care. This is important from public health perspective as 
the fairness keeps incentive for hospitals and reduces barriers to health care access. 
 Finally, the use of prediction modeling for individual patients to investigate the potential 
impact of strategies to prevent SSI contributes to the advancement of science by generating 
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hypotheses to inform research exploring causal inference. Development of prediction models and 
investigation of causal inference differ in principle and model selection but are related. This 
dissertation has identified new potential causal factors of SSI such as abnormal hemoglobin 
levels and white blood cell counts as well as hospital volume and the enrollment in quality 
programs. The results of this dissertation have highlighted research gaps that can be explored in 
future studies. 
 Despite the risk of surgical complications including SSI, these surgeries are essential for 
improving their health-related quality of life and reduce risks of morbidity or death. Therefore, it 
is critical to find ways to mitigate risk of SSI.  As surgical and medical techniques are expanded 
and improved, additional high-risk patients may have opportunity to receive surgical care, but 
the benefits of surgery must outweigh the risks of potential complications such as SSI. It is vital, 
therefore, to investigate efficient preventive strategies as well as to identify high-risk patients. In 
conclusion, this dissertation has highlighted potential risk factors for increased risk of SSI and 
preventive strategies that may reduce this risk in individual pediatric patients undergoing surgery 
for their spinal deformity.
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Appendix 2.1: Risk of bias assessment for included studies 
Checklist Items     First Author 








Reporting              
1. Is the 
hypothesis/aim/objective 
of the study clearly 
described? 
Y Y Y Y Y Y Y Y P Y P Y Y 
2. Are the main outcomes to 
be measured clearly 
described in the 
Introduction or Methods 
section? 
P P P Y Y Y Y Y N Y Y P Y 
3. Are the characteristics of 
the patients included in the 
study clearly described? 
Y Y Y Y Y Y Y Y Y Y Y Y Y 
4. Are the interventions of 
interest clearly described? 
Y Y Y P Y Y Y Y Y Y Y P Y 
5. Are the distributions of 
principal confounders in 
each group of subjects to 
be compared clearly 
described? 
Y N N N Y Y Y Y Y P N N Y 
6. Are the main findings of 
the study clearly 
described? 
Y Y P Y Y Y Y Y Y Y Y Y Y 
7. Does the study provide 
estimates of the random 
variability in the data for 
the main outcomes? 
N Y N N Y Y Y N N Y Y Y Y 
8. Have all important adverse 
events that may be a 
consequence of the 
intervention been reported? 




9. Have the characteristics of 
patients lost to follow-up 
been described? 
N N N N NC NC NC NC NC NC NC N NC 
10. Have actual probability 
values been reported (e.g. 
0.035 rather than <0.05) 
for the main outcomes 
except where the 
probability value is less 
than 0.001? 
Y Y Y Y Y Y Y Y Y Y N Y Y 
External Validity              
11. Were the subjects asked to 
participate in the study 
representative of the entire 
population from which 
they were recruited? 
NA NA NA NA NA NA NA NA NA NA NA NA NA 
12. Were those subjects who 
were prepared to 
participate representative 
of the entire population 
from which they were 
recruited? 
Y N N NC Y P Y Y Y Y Y Y Y 
13. Were the staff, places, and 
facilities where the patients 
were treated, representative 
of the treatment the 
majority of patients 
receive? 
P P NC Y P P P P P P Y P P 
Internal Validity—Bias               
14. Was an attempt made to 
blind study subjects to the 
intervention they have 
received? 
NA NA NA NA NA NA NA NA NA NA NA NA NA 
15. Was an attempt made to 
blind those measuring the 
main outcomes of the 
intervention? 
NA NA NA NA NA NA NA NA NA NA NA NA NA 
16. If any of the results of the 
study were based on “data 




dredging”, was this made 
clear? 
17. In trials and cohort studies, 
do the analyses adjust for 
different lengths of follow-
up of patients, or in case-
control studies, is the time 
period between the 
intervention and outcome 
the same for cases and 
controls? 
N NC NC NC Y Y N Y N Y Y Y Y 
18. Were the statistical tests 
used to assess the main 
outcomes appropriate? 
N Y P P Y Y N N P Y Y P Y 
19. Was compliance with the 
intervention/s reliable? 
Y Y Y Y P Y Y Y Y Y P Y Y 
20. Were the main outcome 
measures used accurate 
(valid and reliable)? 
Y Y Y Y Y Y Y Y NC Y P Y Y 
Internal Validity—
Confounding (Selection Bias) 
             
21. Were the patients in 
different intervention 
groups (trials and cohort 
studies) or were the cases 
and controls (case-control 
studies) recruited from the 
same population? 
P Y Y Y Y Y Y Y Y Y Y Y Y 
22. Were study subjects in 
different intervention 
groups (trials and cohort 
studies) or were the cases 
and controls (case-control 
studies) recruited over the 
same period of time? 
Y Y NC Y N Y N N Y Y Y Y Y 
23. Were study subjects 
randomized to intervention 
groups? 
N N N N N N N N N N N N N 
24. Was the randomized 
intervention assignment 




concealed from both 
patients and health care 
staff until recruitment was 
complete and irrevocable? 
25. Was there adequate 
adjustment for 
confounding in the 
analyses from which the 
main findings were drawn? 
N N N N Y Y P P N N N N N 
26. Were losses of patients to 
follow-up taken into 
account? 
N N N N N N N N N N N N N 
Power              
27. Did the study have 
sufficient power to detect a 
clinically important effect 
where the probability value 
for a difference being due 
to chance is less than 5%? 
NC Y NC Y NC NC NC NC NC NC NC NC NC 
TOTAL              
     Yes 11 12 7 11 14 15 12 12 9 14 11 11 15 
     No 7 6 7 6 3 2 5 5 6 3 5 5 3 
     Partial 3 3 4 3 3 3 3 3 4 3 4 5 2 
     Not clear 2 2 5 3 3 3 3 3 4 3 3 2 3 
     Not applicable 4 4 4 4 4 4 4 4 4 4 4 4 4 
     Quality rating*  P A P P A A A A P A P P A 
JBJS Level of Evidence  T-III  P-II  P-II P-II T-III T-III T-III T-III P-II P-II P-II P-II T-III 
Y=Yes, N=No, P=Partial, NC=Not clear, NA=Not applicable 
JBJS=The Journal of Bone and Joint Surgery 
T-III=Therapeutic Level III Study, P-II=Prognostic Level II Study 
*Rating criteria: good (G): at least 80% of criteria met; average (A): 50% to 80% of criteria met; poor (P): ≤ 50% of criteria met
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Appendix 3.1: Candidate predictor variables 




Age <12 or ≥12 
Gender Male or Female 
Height  Continuous 
Weight Continuous 
BMI 
Normal or Abnormal, Underweight or Not 
Underweight, Overweight/Obese or Not 
Overweight/Obese, Obese or Not obese 
Etiology 
Idiopathic or Not-Idiopathic, Neuromuscular or 
Not Neuromuscular, Syndromic or Not 
Syndromic, Congenital or Not Congenital 
Major Coronal Curve <90 degrees or ≥90 degrees 
Sagittal Curve 
Normal or Abnormal, Hypokyphosis or Not 
Hypokyphosis, Hyperkyphosis or Not 
Hyperkyphosis  
ASA 1, 2, 3, 4 or 5, 1 or ≥2 
Pulmonary Comorbidity Present or Absent  
Cardiac Comorbidity Present or Absent  
Behavioral Comorbidity Present or Absent  
Endocrine Comorbidity Present or Absent  
Gastrointestinal 
Comorbidity 
Present or Absent  
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Immunologic Comorbidity Present or Absent  
Musculoskeletal 
Comorbidity 
Present or Absent  
Neurologic Comorbidity Present or Absent  
Nutritional Comorbidity Present or Absent  
Gastrostomy Tube Present or Absent  
VP Shunt Present or Absent  
Neural Axis Abnormality Present or Absent  
Ambulatory Status Ambulator or Non-Ambulator 
Dipper Dependent  Independent or Dependent 
Hemoglobin 
Low: <10 g/dL or not, Normal:10 to 14 g/dL or 
not, High: >14ƒ g/dL or not 
Hematocrit 
Low:<31% or not, Normal:31% to 48% or not, 
or High:48% or not 
White Blood Cell Count 
Low: <3.5/ul or not, Normal: 3.5 to 12/ul or not, 
or High: >12/ul or not 
Prior Hospitalization within 
2 Years of Surgery  
Yes or No 
Prior SSIs from Any Surgery  Yes or No 
Prior SSIs from Spine 
Surgery 
Yes or No 
Prior Spine Surgeries Yes or No 
Preoperative Halo Traction Yes or No 
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Surgical 
Factors 
Type of Surgery 
Primary Instrumentation or Not, Definitive 
Fusion or Not, Revision or Not, Stapling or Not 
Pelvic Instrumentation Yes or No 
Intraoperative Skeletal 
Traction  
Yes or No 
Transfusion Yes or No 
Use of Cell Saver Yes or No 
Number of Level 
Instrumented  
≥15 or <15 
Type of Instrumentation Hybrid or Screw Only 





Yes or No 
Skin Closure Staple or Not 
Hospital 
Factors 
Geographic Region Northeast or West 
Area Urban or Rural 
Academic Health Center Yes or No 
Institutional Spine Surgical 
Volume 
<100 or ≥100 
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Preoperative Patient Characteristics 
Age was examined as a continuous variable and also dichotomized using 8, 10 12 and 14 years 
of age as cutoffs. Gender was coded as a dichotomous variable (female or male). BMI were 
calculated using the CDC equation69 for children and adolescents depending on gender and age. 
BMI < 5th percentile, 5th to< 85th percentile, and ≥85th percentile will be considered 
underweight, normal, and overweight/obese, respectively. Etiology were categorized 
into congenital, neuromuscular, syndromic, idiopathic and others and further be dichotomized 
into idiopathic or non-idiopathic.   
The magnitude of spinal deformities was first measured in degrees of coronal and sagittal 
curvatures using Cobb method as continuous variables. Coronal curvatures were defined as the 
largest Cobb measures70 on upright long cassette of spine shown in coronal radiograph. Coronal 
curvatures were further be dichotomized into less than 70 degrees more and less than 90 degrees 
or more as 70 or 90 degrees are considered large spinal curves. Sagittal curvatures were 
measured by sagittal radiographs using T1-T12 column, and categorized into normal (20 to 50 
degrees), hypokyphosis (smaller than the normal range) and hyperkyphosis (larger than the 
normal range).  They were further dichotomized into normal and abnormal (hypokyphosis or 
hyperkyphosis).   
Health status of patients included American Society of Anesthesiologists’ (ASA) 
classification of physical status defined as a global score assessing the physical status of patients 
before surgery140. The ASA scores 1 though 5 were further be dichotomized into stage 1 or >1 
and 1-2 or >2 to compare relatively healthy patients and patients with some degree of systemic 
disease. Comorbidities included pulmonary (e.g. asthma, restrictive airway disease), cardiac (e.g. 
valve disorders, congenital heart defects), behavioral disorder/delay (e.g. developmental delay, 
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attention deficit hyperactivity disorder), endocrine (e.g. diabetes, hypothyroidism), 
gastrointestinal (e.g. gastrointestinal reflux disease, hiatal hernia), immunologic (e.g. eczema, 
allergies), musculoskeletal (e.g. myopathies), neurologic (e.g. myelomeningocele, seizures) 
and nutritional (e.g. failure to thrive). These comorbidities were recorded as present or 
absent. Similarly, presence of a gastrostomy tube, a ventriculoperitoneal shunt and a neural axis 
abnormality were documented as present or absent. The following variables were dichotomized 
as follows: ambulatory status (ambulatory or non-ambulator); diaper dependence (independent or 
dependent); preoperative Halo traction (yes/no).  
Preoperative laboratory data consisted of hemoglobin, hematocrit and white blood cell 
count. Hemoglobin values were categorized into low (<10 gm/dL), normal (10 to 14 gm/dL) 
or high >14 gm/dL) and further be dichotomized into normal or abnormal (low or 
high). Hematocrit levels were categorized into low (<31%), normal (31% to 48%), or high 
(>48%) and further be dichotomized into normal or abnormal (low or high). White blood cell 
counts were categorized into low (<3,500 mcL), normal (3,500 to 12,000 mcL), or high 
(>12,000 mcL) and further dichotomized into normal or abnormal (low or high).   
The data also included history of hospitalization for a non-orthopaedic reason within 2 
years of the date of surgery (yes/no), history of prior SSIs from any surgical 
procedure, (yes/no), history of prior SSIs from spine surgery specifically (yes/no), and history of 
prior spine surgeries (yes/no). 
  
Preoperative known Surgical Factors  
Type of spinal surgery included primary fusion, revision instrumentation, definitive fusion or 
stapling.  Pelvic instrumentation, defined as instrumentation extended to sacrum or ilium, was 
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recorded as dichotomous variable (yes/no). Utilization of intraoperative skeletal traction was 
recorded as dichotomous variable (yes/no) and type of traction includes halo, lower extremity or 
pelvic skeletal traction. Number of instrumentation level, defined as a total number of vertebral 
columns connected to single or two rods, was first be analyzed as continuous variable and later 
investigated to see if there was threshold value that was meaningful in terms of SSI. Duration of 
surgery was investigated first as a continuous variable and then as dichotomous variable to see if 
there was any meaningful cutoff. Transfusion was coded as dichotomous variable(yes/no). Cell 
saver was each be coded as dichotomous variable (yes/no). Type of instrumentation was be 
classified into screw use only or hybrid defined as using both screw and hook. Spinal 
osteotomies and 3-column pedicle subtraction osteotomy (PSO)/vertebral column resection 
(VCR) was coded as performed or not performed. The data also included the use of skin closure 
(no staples/staples).  
 
Hospital Factors  
The dataset included multiple institutions and these hospital sites were categorized by geographic 
region (West, Midwest, Northeast, Southwest, Southeast), urban or rural, and 
academic affiliation or not. Institutional surgical volumes per year for pediatric spine surgery 




Appendix 3.2: Method for handling missing data 
 Multiple imputations, one of the most popular simulation-based methods for incomplete data analysis, were used to handle 
missing values in candidate predictor variables. The multiple imputation technique was chosen to reserve sample size while 
minimizing bias and correcting standard errors for uncertainty due to missing data. The missing data for candidate predictive variables 
were assumed to be missing completely at random (MCAR) since reasons that data were missing were not associated with the surgical 
site infection (SSI) and the distribution of missing data was balance in those with and without SSI. Variables to be included in 
multiple imputation model were chosen based on univariable analyses. For each candidate predictive variables with missing values, 20 
datasets were imputed.  
 
 
Number (%) of missing values per candidate predictor variables, and distribution of predictors among subjects without and 
with missing values (100%:N=3092) 
 
Candidate Predictor Variables No 
Missing 



















Preoperative Patient Characteristics 
Age in years, mean± SD (range) 3,092 
(100%) 
0 (0%) 13.0±4.1  
[12.9; 13.2] 
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Type of Surgery, 
Surgical Volume 
20 






5.9 ± 2.3 
[5.8; 6.0] 
5.8 ± 2.6 
[5.7; 5.9] 
















































NA NA NA NA 




0 (0%) 73.8 ± 74.0  
(1.6; 220) 
NA NA NA NA 
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Appendix 3.3: Five-fold cross validation 
 
 Since the model were likely to have a large number of parameters, it was possible that the 
model overfits the data. Therefore, five-fold cross-validation was performed to determine the 
presence of overfit, which is indicated by within-sample error being considerably smaller than 
out-of-sample error. The five-fold cross-validation allowed us to estimate the out-of-sample error 
by dividing data into a training set which fits the model and a test set which evaluates 
performance (estimates error). First, the entire dataset was divided into five equal sized subsets 
(see below figure). For each of five experiments, we utilized four folds as training set to fit the 
model and produce parameter estimates. Then an AUC and standard error for the training set 
were calculated. Next, use the fitted model on the remaining one-fold to produce AUC and 
standard error in the testing set. The within-sample error was estimated as the average error on 
training set and the out-of-sample error was estimated as the average error on test sets. This five-
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% of SSI 
3% 4% 5% 6% 7% 8% 9% 10% 11% 12% 
Number of SSI 
1,500 45 60 75 90 105 120 135 150 165 180 
2,000 60 80 100 120 140 160 180 200 220 240 
2,500 75 100 125 150 175 200 225 250 275 300 
3,000 90 120 150 180 210 240 270 300 330 360 
3,500 105 140 175 210 245 280 315 350 385 420 
4,000 120 160 200 240 280 320 360 400 440 480 
4,500 135 180 225 270 315 360 405 450 495 540 
5,000 150 200 250 300 350 400 450 500 550 600 
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Model Comparisons 
Alpha Sample Size 
(Procedures) 
Power 
AUC Difference -/+0.02 AUC Difference -/+0.03 
0.72 0.76 0.80 0.84 0.72 0.76 0.80 0.84 
0.05 1,055 0.41 0.41 0.42 0.45 0.74 0.74 0.76 0.79 
0.05 1,060 0.41 0.41 0.42 0.45 0.74 0.74 0.76 0.80 
0.05 1,150 0.44 0.44 0.45 0.48 0.77 0.77 0.79 0.83 
0.05 1,175 0.45 0.45 0.46 0.49 0.78 0.78 0.80 0.84 
0.05 1,200 0.45 0.45 0.47 0.50 0.79 0.79 0.81 0.84 
0.05 1,225 0.46 0.46 0.48 0.51 0.80 0.80 0.82 0.85 
0.05 1,250 0.47 0.47 0.48 0.52 0.80 0.81 0.82 0.86 
0.05 1,500 0.54 0.54 0.56 0.59 0.87 0.87 0.89 0.91 
0.05 2,000 0.66 0.66 0.68 0.72 0.95 0.95 0.96 0.97 
0.05 2,400 0.74 0.74 0.76 0.80 0.97 0.98 0.98 0.99 
0.05 2,500 0.76 0.76 0.78 0.81 0.98 0.98 0.98 0.99 
0.05 2,600 0.77 0.78 0.79 0.83 0.98 0.98 0.99 0.99 
0.05 2,650 0.78 0.78 0.80 0.83 0.98 0.98 0.99 0.99 
0.05 2,750 0.80 0.80 0.81 0.85 0.99 0.99 0.99 0.99 




Appendix 3.5: Descriptive statistics for candidate predictors before multiple imputations 
 
 The distribution of study participants was examined before the imputation for each candidate predictive variables. The 95% 
confidence intervals for mean value or proportionality was presented for each imputed candidate predictor variables.  
 
 Descriptive Analyses Univariable Regression
  
Candidate Predictor Variables Observed N 
(% of Total 
N=3092) 








Preoperative Patient Characteristics       
Age in years, mean± SD [95% CI] 3,092 
(100%) 
13.0±4.1 













































0.63 [0.28; 0.98] <0.001 





















































































































































































-0.11 [-0.74; 0.52] 0.729 


















































<90 2,646 (90.9%) 2,544 (91.1%) 102 (3.9%) 

























0.35 [-0.17; 0.86] 






























































1.15 [0.28; 2.02] 
2.20 [1.37; 3.04] 
2.36 [1.20; 3.53] 
































































































































-0.15 [-0.06; 0.76] 0.748 





























































































































0.85 [0.43; 1.27] <0.001 


















1.14 [0.48; 1.80] 0.001 




























































1.36 [0.95; 1.77] <0.001 
HGB in g/dl, mean± SD [95% CI] 2,874 
(92.9%) 
13.2 ± 1.5 
[13.2; 12.3] 
13.2 ± 1.5 
[13.1; 13.3] 
13.2 ± 1.7 
[12.9; 13.5] 
-0.02 [-0.13; 0.10] 0.784 
HGB in g/dl  
 
Low: <10  















0.79 [0.04; 1.53] 0.040 






















0.52 [0.16; 0.89] 0.004 
HGB in g/dl  
 
High >14 















0.41 [0.04; 0.78] 0.032 
HCT in %, mean± SD [95% CI] 2,823 
(91.3%) 
39.2 ± 4.2 
[39.1; 39.4] 
39.2 ± 4.2 
[39.1; 39.4] 
39.4 ± 4.7 
[38.6; 40.2] 
0.01 [-0.03; 0.05] 0.695 
HCT in %  
 
Low: <31 















0.07 [-0.84; 0.99] 0.877 


























HCT in %  
 
High: >48 















-0.45[-2.44; 1.55] 0.662 
WBC in #/ul, mean± SD [95% CI] 2,853 
(92.3%) 
7.1 ± 3.0 
 [7.0; 7.2] 
7.1 ± 3.1 
[7.0; 7.2] 





WBC in #/ul  
 
Low: <3.5 















-0.66 [-1.597; 0.24] 0.151 






















0.06 [-0.46; 0.58] 0.819 
WBC in #/ul  
 
High: >12 















0.62 [0.002; 1.24] 0.049 
Hospitalization 



















0.41 [0.02; 0.80] 0.037 


















0.53 [-0.17; 1.24]  
0.135 































































0.15 [-0.63; 0.93] 0.705 
Surgical Factors       


































0.38 [-0.23; 0.78] 









































































































0.35 [-0.02; 0.90] 0.216 




10.9 ± 4.8 
[10.8; 11.1] 
10.9 ± 4.8 
[10.8; 11.1] 



























































































-1.49 [-3.47; 0.49] 0.140 


















0.57 [0.17; 0.97] 0.005 


















































5.9 ± 2.3 
[5.8; 6.0] 
5.9 ± 2.3 
[5.8;6.0] 
7.1 ± 2.7 
[6.6;7.6] 
0.01 [0.005; 0.012] <0.001 



















1.10 [0.70; 1.51] <0.001 


































































73.8 ± 74.0 
[71.2; 76.4] 
74.4 ± 74.4 
[71.8; 77.1] 

























0.39 [0.02; 0.76] 0.039 
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Appendix 3.6: Comparisons of average discrimination and calibrations in eight developed 
models 
 
The model discrimination was assessed using receiver operating characteristic (ROC) curves, 
discrimination slopes along with box plots, and Lorenz curves. The ROC plotted sensitivity vs 1-
specificity and calculated the area under the curve (AUC) ranging from 0.5 (no discriminative 
ability) to 1 (perfect discrimination)100. The discrimination slopes were calculated as the average 
difference in predictions between patients with and without SSI97. The Lorenz curves plotted the 
proportion of patients with SSI against the cumulative proportion of the study subjects ranked by 
predicted SSI risk141. A good model had almost horizontal line until the 50% cumulative 
proportion risk point (low proportion of SSI at 25% and 50%) and rose steeply from the point 
(large proportion of SSI left above 50% and 75%). Three different methodologies were utilized 
for discrimination as each had advantages and disadvantages. Discrimination slopes along with 
box plots provided easy interpretation and clear visualization but heavily influenced by the low 
incidence of the SSI. Lorenz curves demonstrated clear balance between patients with true 
positives against patients classified as positive but were also influenced by low incidence of the 
SSI. The evaluation of ROC on the other hand was insensitive to the low incidence of the SSI 
however the situation that interpretation was derived from was rather artificial. The AUC could 
be interpreted as the probability of patient with SSI receiving higher probability of SSI by the 
prediction model than a random pair of a patient without SSI. Although the evaluation of 
discrimination using AUC is widely utilized in the medical literature, the assumption that we 
would have a pair of patients with SSI and without SSI were rather artificial situation. Therefore, 
multiple methodologies were used to compare discrimination abilities among models.   
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 In order to evaluate calibration abilities, calibration plots, values of calibration-in-the-
Large, calibration slopes, and Hosmer-Lemeshow (H-L) goodness-of-fit-tests. The calibration 
plots compared the mean predictions against the mean observed outcome for patients grouped by 
ten similar probabilities (decile)142. Better prediction models had more distance between each 
decile group than models with poor predictions. The calibration-in-the-Large referred to the 
difference between the mean of the outcomes and the mean of predictions97. Calibration slopes 
represented the amount of shrinkage needed to on average to make better calibration for the new 
set of patients from the underlying population143. Non-significant p values in the H-L goodness-
of-fit-tests reflected the ability of developed models to fit the data144. Although the H-L 
goodness-of-fit-test is commonly used test for binary outcome, it is sensitive to sample size as 
large samples yield significant p values despite the fit itself; therefore, other performance 
measures were utilized to assess model ability to calibrate.  
 Appendix 3.6a described candidate predictor variables included in each model and 
average values of discrimination and calibration performance measures. Appendix 3.6b 
demonstrated visualizations and values of five-fold cross validations in the model. The dotted 
line in calibration plots denoted the reference line and ten circles represents ten groups. The blue 
line represented a LOWESS (locally weighted scatterplot smoothing) describing relationship 




Appendix 3.6a: Candidate prediction models and average values of discrimination and calibration abilities from five-fold cross 
validation 
 
Candidate Prediction Models 
 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 
Age: <12 X   X X X X 
Male X   X   X 
BMI Abnormal        
BMI Overweight/Obese X X X X X X X 
Neuromuscular Etiology X X X X X X X 
Major Coronal Curve:  
≥70 ° 
       
ASA >2 X X X X X X X 
Pulmonary Comorbidity X   X X   
Behavioral Comorbidity        
MSK Comorbidity X       
Neurologic Comorbidity        




Non-Ambulatory X X X X X X X 
Diaper Dependent X X  X X X X 
Abnormal HGB: <10 or 
>14g/dL 
X X X X X X X 
Hospitalization within 2 
years 
       
Prior Spine Surgery        
Revision Surgery X X X X X X X 
Pelvic Instrumentation X X X X X X X 
Instrumented Levels: ≥15        
Transfusion         
Procedure Time: ≥7 hours X X X X X X X 
Spine Surgical Volume: 
<100 cases 
X X X X X X X 
Training Set N=2,474 (80% of N=3,092) 
Area Under Curve, %  



















(mean, SE)  
[95% CI] 
[0.04; 0.06] [0.04; 0.06] [0.04; 0.06] [0.04; 0.06] [0.04; 0.06] [0.04; 0.06] [0.04; 0.06] 
Lorenz Curve, %  















Expected/Observed Ratio 0.99 0.99 0.99 0.99 0.99 0.99 0.99 
Calibration-in-the-Large 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Calibration Slope 1.04 1.03 1.04 1.04 1.04 1.04 1.04 
Hosmer-Lemeshow 
Goodness-of-Fit 
0.03 0.01 0.01 0.01 0.01 0.003 0.01 
Testing Set N=618 (20% of N=3,092) 
Area Under Curve, % 















Discrimination Slope  
















Lorenz Curve, % 



















Calibration-in-the-Large 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
Calibration Slope 0.91 0.98 0.98 0.93 0.94 1.04 0.95 
Hosmer-Lemeshow 
Goodness-of-Fit 
0.29 0.44 0.44 0.32 0.40 0.36 0.31 
Deviance  0.99 0.99 0.99 0.99 0.99 0.99 0.99 










Training Sample (N=2,474) Testing Sample (N=618) 
Discrimination Calibration Discrimination Calibration 
ROC Curve 
 
Slope and Box 
Plot 
Lorenz Curve Calibration Plot ROC Curve Slope and Box 
Plot 

































HL GOF: 0.001 HL GOF: 0.19 
CITL: 0.01 CITL: 0.03 
Slope: 1.04 Slope: 0.67 
Experiment 2 
Training Sample (N=2,474) Testing Sample (N=618) 
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ROC Curve Slope and Box 
Plot 
Lorenz Curve Calibration Plot ROC Curve Slope and Box 
Plot 

































HL GOF: 0.02 HL GOF: 0.05 
CITL: 0.01 CITL: 0.10 
Slope: 1.04 Slope: 0.78 
Experiment 3 
Training Sample (N=2,474) Testing Sample (N=618) 
Discrimination Calibration Discrimination Calibration 
ROC Curve Slope and Box 
Plot 
Lorenz Curve Calibration Plot ROC Curve Slope and Box 
Plot 
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CITL: 0.01 
   
CITL: -0.01 
Slope: 1.04 Slope: 1.36 
Experiment 4 
Training Sample (N=2,474) Testing Sample (N=618) 
Discrimination Calibration Discrimination Calibration 
ROC Curve Slope and Box 
Plot 
Lorenz Curve Calibration Plot ROC Curve Slope and Box 
Plot 


































HL GOF: 0.001 HL GOF: 0.12 
CITL: 0.01 CITL: -0.04 
Slope: 1.02 Slope: 1.00 
Experiment 5 
Training Sample (N=2,474) Testing Sample (N=618) 
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ROC Curve Slope and Box 
Plot 
Lorenz Curve Calibration Plot ROC Curve Slope and Box 
Plot 



































HL GOF: 0.34 
CITL: 0.01 CITL: -0.01 
Slope: 1.04 Slope: 1.12 
Average of Five Experiments 
Training Sample (N=2,474) Testing Sample (N=618) 
Discrimination Calibration Discrimination Calibration 
ROC Curve Slope and Box 
Plot 
Lorenz Curve Calibration Plot ROC Curve Slope and Box 
Plot 
Lorenz Curve Calibration Plot 
AUC: 0.77 
SE: 0.02 
95% CI:  
Slope: 0.05 
SE: 0.004 
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0.73; 0.82 0.04; 0.06 CITL: 0.01 0.68; 0.85 0.03; 0.06 CITL: 0.01 
Slope: 1.04 Slope: 0.99 
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Appendix 4.1: Preventive Care Factors 
Type of Preventive Care Factors Measures 
Topical vancomycin Dichotomous (yes or no) 
Povidone-iodine irrigations Dichotomous (yes or no) 
Multi-layer closure Dichotomous (performed or not 
performed) 
Dressing Dichotomous (permeable or 
impermeable) 
Children’s Hospitals’ Solutions for Patient Safety or  
Comprehensive Unit-based Safety Program 
enrollment 
Dichotomous (yes or no) 
Preoperative dosing of any IV antibiotics Dichotomous (correct or incorrect) 
Preoperative timing of any IV antibiotics Dichotomous (correct or incorrect) 
Intraoperative dosing of any IV antibiotics Dichotomous (correct or incorrect) 
Intraoperative timing of any IV antibiotics Dichotomous (correct or incorrect) 
Postoperative dosing of any IV antibiotics Dichotomous (correct or incorrect) 
Postoperative timing of any IV antibiotics Dichotomous (correct or incorrect) 
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Appendix 4.2: Perioperative antibiotic prophylaxis regimen for 























15 to 60 
min prior 
to incision  
 
Eligible for redosing if 
surgery duration ≥4 h after 
first antibiotic dose. Timing 
of intraoperative redosing: 4 




antibiotics within 24 h 
of surgery end time. 
Postoperative 
redosing interval: 













15 to 60 
min prior 
to incision  
 
Eligible for redosing if 
surgery duration ≥8 h after 
first antibiotic dose. Timing 
of intraoperative redosing: 8 




antibiotics within 24 h 
of surgery end time. 
Postoperative 
redosing interval: 
every 8 h 
 















15 to 60 
min prior 
to incision  
 
Eligible for redosing if 
surgery duration ≥8 h after 
first antibiotic dose. Timing 
of intraoperative redosing: 8 




antibiotics within 24 h 
of surgery end time. 
Postoperative 
redosing interval: 









Powder rubbed into spinal 
muscles  
 



















Appendix 4.3: Number (%) of missing values per candidate predictor variables, and distribution of predictors among subjects 










































































Arbitrary Age, Etiology, 
Halo Traction, 






















































Arbitrary Etiology, Prior 
Spine Surgery, 
Halo Traction, 






CUSP/ SPS  
 
Enrolled  






























Appendix 4.4: Predictive discrimination and calibration abilities in the training and testing sets in the five-fold cross validation 
 
Model with Preventive Care Factors 
Experiment 1 
Training Sample (N=2,474) Testing Sample (N=618) 
Discrimination Calibration Discrimination Calibration 
ROC Curve Slope and 
Box Plot 
Lorenz Curve Calibration 
Plot 
ROC Curve Slope and 
Box Plot 


































HL GOF: 0.01 HL GOF: 
<0.001 
CITL: 0.01 CITL:0.02 
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Training Sample (N=2,474) Testing Sample (N=618) 
Discrimination Calibration Discrimination Calibration 
ROC Curve Slope and 
Box Plot 
Lorenz Curve Calibration 
Plot 
ROC Curve Slope and 
Box Plot 






































CITL: 0.01 CITL: 0.10 
Slope: 1.03 Slope: 0.87 
Experiment 3 
Training Sample (N=2,474) Testing Sample (N=618) 
Discrimination Calibration Discrimination Calibration 
ROC Curve Slope and 
Box Plot 
Lorenz Curve Calibration 
Plot 
ROC Curve Slope and 
Box Plot 
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CITL: 0.01 CITL:-0.01 
Slope: 1.03 Slope: 1.40 
Experiment 4 
Training Sample (N=2,474) Testing Sample (N=618) 
Discrimination Calibration Discrimination Calibration 
ROC Curve Slope and 
Box Plot 
Lorenz Curve Calibration 
Plot 
ROC Curve Slope and 
Box Plot 
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CITL: 0.01 CITL: -0.04 
Slope: 1.02 Slope: 0.91 
Experiment 5 
Training Sample (N=2,474) Testing Sample (N=618) 
Discrimination Calibration Discrimination Calibration 
ROC Curve Slope and 
Box Plot 
Lorenz Curve Calibration 
Plot 
ROC Curve Slope and 
Box Plot 
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Average of Five Experiments 
Training Sample (N=2,474) Testing Sample (N=618) 
Discrimination Calibration Discrimination Calibration 
ROC Curve Slope and 
Box Plot 
Lorenz Curve Calibration 
Plot 
ROC Curve Slope and 
Box Plot 













E:O=0.99 AUC: 0.77 
SE: 0.04 














CITL: 0.01 CITL: 0.01 
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